Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ECOLAB INC. Annual Report 2007

Feb 25, 2008

29912_10-k_2008-02-25_1b2a6856-cd4c-4a0b-9b7e-8ce86e65f64c.zip

Annual Report

Open in viewer

Opens in your device viewer

10-K 1 a08-6080_110k.htm 10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

*Washington, D.C. 20549*

*FORM 10-K*

*(Mark One)*

x
SECURITIES EXCHANGE ACT OF 1934

For the Fiscal Year Ended December 31, 2007 Commission File No. 1-9328

o
SECURITIES EXCHANGE ACT OF 1934

*For the transition period from to*

*ECOLAB INC.*

(Exact name of registrant as specified in its charter)

Delaware 41-0231510
(State or other
jurisdiction of incorporation or organization) (I.R.S. Employer
Identification No.)
370
Wabasha Street North, St. Paul, Minnesota 55102
(Address of
principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: 1-800-232-6522

Securities registered pursuant to Section 12(b) of the Act:

| Title of
each class | Name of
each exchange on which registered |
| --- | --- |
| Common Stock,
$1.00 par value | New York Stock
Exchange, Inc. |
| Preferred Stock
Purchase Rights | New York Stock
Exchange, Inc. |

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

x YES o NO

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

o YES x NO

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

x YES o NO

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer x Accelerated filer o Non-accelerated filer o (Do not check if a smaller reporting company) Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

o YES x NO

Aggregate market value of voting and non-voting common equity held by non-affiliates of registrant on June 30, 2007: $10,446,188,400 (see Item 12, under Part III hereof), based on a closing price of registrant’s Common Stock of $42.70 per share.

The number of shares of registrant’s Common Stock, par value $1.00 per share, outstanding as of January 31, 2008: 247,200,121 shares.

DOCUMENTS INCORPORATED BY REFERENCE

  1. Portions of the registrant’s Annual Report to Stockholders for the year ended December 31, 2007 (hereinafter referred to as “Annual Report”) are incorporated by reference into Parts I and II.

  2. Portions of the registrant’s Proxy Statement for the Annual Meeting of Stockholders to be held May 2, 2008 and to be filed within 120 days after the registrant’s fiscal year ended December 31, 2007 (hereinafter referred to as “Proxy Statement”) are incorporated by reference into Part III.

SEQ.=1,FOLIO='',FILE='C:\JMS\mvreela\08-6080-1\task2713946\6080-1-ba-01.htm',USER='mvreela',CD='Feb 21 19:48 2008'

*TABLE OF CONTENTS*

PART I
Forward-Looking Statements
Item 1(a) General Development of
Business
Item 1(b) Financial Information About
Operating Segments
Item 1(c) Narrative Description of
Business
Item 1(d) Financial
Information About Geographic Areas
Item 1(e) Available
Information
Executive
Officers of the Company
Item 1A. Risk Factors
Item 1B. Unresolved
Staff Comments
Item 2. Properties
Item 3. Legal Proceedings
Item 4. Submission
of Matters to a Vote of Security Holders
PART II
Item 5. Market for
Registrant’s Common Equity, Related Stockholder Matters and Issuer purchases
of Equity Securities
Item 6. Selected
Financial Data
Item 7. Management’s
Discussion and Analysis of Financial Condition and Results of Operation
Item 7A. Quantitative
and Qualitative Disclosures about Market Risk
Item 8. Financial
Statements and Supplementary Data
Item 9. Changes in
and Disagreements with Accountants on Accounting and Financial Disclosure
Item 9A. Controls and
Procedures
Item 9B. Other Information
PART III
Item 10. Directors,
Executive Officers of the Registrant and Corporate Governance
Item 11. Executive
Compensation
Item 12. Security
Ownership of Certain Beneficial Owners and Management and Related Stockholder
Matters
Item 13. Certain
Relationships and Related Transactions
Item 14. Principal
Accountant Fees and Services
PART IV
Item 15. Exhibits and
Financial Statement Schedules
SIGNATURES
CONSENT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EXHIBIT INDEX

SEQ.=1,FOLIO='',FILE='C:\JMS\mvreela\08-6080-1\task2713946\6080-1-ba-01.htm',USER='mvreela',CD='Feb 21 19:48 2008'

PART I

Except where the context otherwise requires, references in this Form 10-K to either “Ecolab,” “Company,” “we” and “our” are to Ecolab Inc. and its subsidiaries, collectively.

*Forward-Looking Statements*

This Annual Report on Form 10-K, including “Management’s Discussion and Analysis of Financial Condition and Results of Operation” incorporated by reference into Item 7 of this Form 10-K, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include expectations concerning business progress and expansion, business acquisitions, currency translation, cash flows, debt repayments, environmental and regulatory considerations, share repurchases, global economic conditions, pension expenses and potential contributions, income taxes and liquidity requirements. Without limiting the foregoing, words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “we believe,” “we expect,” “estimate,” “project” (including the negative or variations thereof) or similar terminology, generally identify forward-looking statements. Forward-looking statements may also represent challenging goals for us. We caution that undue reliance should not be placed on such forward-looking statements, which speak only as of the date made. Some of the factors which could cause results to differ from those expressed in any forward-looking statement are set forth under Item 1A of this Form 10-K, entitled Risk Factors.

*Item 1. Business* .

*Item 1(a) General Development of Business* .

Ecolab was incorporated as a Delaware corporation in 1924. Our fiscal year is the calendar year ending December 31.

During 2007, we continued to make business acquisitions to broaden our product offerings and expand our geographic coverage, consistent with our “Circle the Customer – Circle the Globe” strategy.

In January 2007, we established a direct operation in the United Arab Emirates. We previously operated in the country through a distributor, and purchased that business to form the new direct operation in the country. Annual sales are approximately $3 million and became part of our International operations beginning in the first quarter of 2007.

In February 2007, we acquired Apprise Technologies, Inc., a Minnesota-based developer of optical sensor technology solutions. Annual sales are approximately $1 million and became part of our U.S. Cleaning & Sanitizing operations beginning in the first quarter of 2007.

In March 2007, we acquired Green Harbour, a Hong Kong-based provider of pest elimination services in China and Hong Kong. Annual sales are approximately $4 million and became part of our International operations beginning in the second quarter of 2007.

In May 2007, we acquired Fuma Pest, a New Zealand-based provider of pest elimination services. Annual sales are approximately $2 million and became part of our International operations beginning in the second quarter of 2007.

In June 2007, we acquired Eagle Environmental Systems, a provider of pest elimination services based in Sydney, Australia. Annual sales are approximately $4 million and became part of our International operations beginning in the third quarter of 2007.

In September 2007, we made a minority investment in Site Controls, LLC, a leading provider of energy management and business intelligence solutions.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\mvreela\08-6080-1\task2713946\6080-1-ba-01.htm',USER='mvreela',CD='Feb 21 19:48 2008'

In November 2007, we acquired Microtek Medical Holdings, Inc., a manufacturer and marketer of infection control products for healthcare and acute care facilities. Microtek’s specialized product lines include infection barrier equipment drapes, patient drapes, fluid control products and operating room cleanup systems. Microtek’s 2006 sales were approximately $150 million and became part of our U.S. Cleaning & Sanitizing and International operations.

Regarding business dispositions, we completed the sale of Peter Cox Limited, a leading United Kingdom provider of damp proofing, waterproofing, timber preservation and wall stabilization for residential, commercial and public properties, in September 2007. We acquired Peter Cox Limited in connection with our 2002 purchase of the Terminix Pest Control business in the United Kingdom. 2006 revenues for the Peter Cox business were GBP 16 million (approximately $32 million).

Additional details regarding certain of the above transactions are found in Note 5 located on pages 35 and 36 of the Annual Report, and incorporated into Item 8 of this Form 10-K.

*Item 1(b) Financial Information About Operating Segments* .

The financial information about reportable segments appearing under the heading “Operating Segments” in Note 16, located on pages 45 and 46 of the Annual Report, is incorporated herein by reference.

*Item 1(c) Narrative Description of Business* .

**General** : Ecolab develops and markets premium products and services for the hospitality, foodservice, healthcare and industrial markets. We provide cleaning and sanitizing products and programs, as well as pest elimination, maintenance and repair services primarily to hotels and restaurants, healthcare and educational facilities, quick-service (fast-food and other convenience store) units, grocery stores, commercial and institutional laundries, light industry, dairy plants and farms, food and beverage processors and the vehicle wash industry. A strong commitment to customer support and sustainable solutions is a distinguishing characteristic of our business. Additional information on our business philosophy is found below under the heading “Additional Information – Competition” of this Item 1(c).

The following description of our business is based upon our three reportable segments as reported in our consolidated financial statements. However, we pursue a “Circle the Customer – Circle the Globe” strategy by providing products, systems and services which serve our customer base, and do so on a global basis to meet the needs of our customers’ various operations around the world. Therefore, one customer may utilize the products or services of all three of the segments and there is interdependence among the operating segments. Revenues of our International segment include sales outside the United States by our Kay and Pest Elimination businesses.

*United States Cleaning & Sanitizing Segment*

The “United States Cleaning & Sanitizing” segment is comprised of seven business units which provide cleaning and sanitizing products and programs to United States markets.

**Institutional**** : Our Institutional Division is our largest division and sells specialized cleaners and sanitizers for washing dishes, glassware, flatware, foodservice utensils and kitchen equipment (“warewashing”), for on-premise laundries (typically used by hotel and health care customers) and for general housekeeping functions, as well as food safety products and equipment, dishwasher racks and related kitchen sundries to the foodservice, lodging, educational and healthcare industries, and water filters to the foodservice industry. The Institutional Division also provides pool and spa treatment programs for hospitality and other commercial customers. The Institutional Division manufactures and markets various chemical dispensing device systems, which are made available to customers, to dispense our cleaners and sanitizers. In addition, the Institutional Division markets a lease program comprised of energy-efficient dishwashing machines, detergents, rinse additives and sanitizers, including full machine maintenance.

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\mvreela\08-6080-1\task2713946\6080-1-ba-01.htm',USER='mvreela',CD='Feb 21 19:48 2008'

We believe we are the leading supplier of chemical warewashing products and programs to institutions in the United States.

The Institutional Division sells its products and programs primarily through company-employed field sales personnel. However, to a significant degree, we also utilize independent, third-party foodservice distributors to market and sell our products to smaller accounts or accounts which purchase through food distributors. We provide the same customer support to accounts supplied by food distributors as to direct customers.

Effective January 1, 2007, we integrated our former Professional Products division into the Institutional Division to deliver a broad range of cleaning and floor care products and programs to customers in hospitality, health care and commercial facilities. The Institutional sales force, along with a network of independent, third-party distributors serving the commercial janitorial industry, market Professional Products’ proprietary offerings (detergents, general purpose cleaners, carpet care, stone care, furniture polishes, disinfectants, floor care products, hand soaps and odor counteractants).

**Kay**** : Our Kay Division (which consists of certain wholly-owned subsidiaries of Ecolab Inc.) supplies chemical cleaning and sanitizing products primarily to national and regional quick-service restaurant chains. Kay’s products include specialty and general purpose hard surface cleaners, degreasers, sanitizers, polishes, hand care products and assorted cleaning tools. Products are sold under the “Kay” brand or the customer’s private label. In addition, Kay supports its product sales with employee training programs and technical support designed to meet the special needs of its customers. Kay’s customized cleaning and sanitation programs are designed to reduce labor costs and product usage while increasing sanitation levels, cleaning performance, equipment life and safety levels.

Kay employs a direct field sales force which primarily calls upon national and regional quick-service restaurants and franchisees, although the sales are made to distributors who supply the chain or franchisee’s units.

We believe that our Kay Division is the leading supplier of chemical cleaning and sanitizing products to the traditional quick-service restaurant industry in the United States. While Kay’s customer base has been growing, Kay’s business is largely dependent upon a limited number of major quick-service restaurant chains and franchisees. Kay continues to seek growth and diversification opportunities.

In addition, through Kay’s Food Retail business, the Division supplies cleaning and sanitizing products to the food retail (i.e., grocery store) industry. Food Retail products are sold primarily through distributors and include specialty and general purpose hard surface cleaners, degreasers, sanitizers, polishes, hand care products, assorted cleaning tools and floor care products. We provide the same customer support to accounts supplied by distributors as to direct customers.

**Food & Beverage**** : Our Food & Beverage Division addresses cleaning and sanitation at the beginning of the food chain to facilitate the production of products for human consumption. The Division provides detergents, cleaners, sanitizers, lubricants and animal health products, as well as cleaning systems, electronic dispensers and chemical injectors for the application of chemical products, primarily to dairy plants, dairy farms, breweries, soft-drink bottling plants, and meat, poultry and other food processors. The Food & Beverage Division is also a leading developer and marketer of antimicrobial products used in direct contact with meat, poultry, seafood and produce during processing in order to reduce microbial contamination on those surfaces. The Division also designs, engineers and installs CIP (“clean-in-place”) process control systems and facility cleaning systems for its customer base. Farm products are sold through dealers and independent, third-party distributors, while plant products are sold primarily by our field sales personnel.

We believe that we are one of the leading suppliers of cleaning and sanitizing products to the dairy plant, dairy farm, food, meat and poultry, and beverage/brewery processor industries in the United States.

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\mvreela\08-6080-1\task2713946\6080-1-ba-01.htm',USER='mvreela',CD='Feb 21 19:48 2008'

**Textile Care**** : Our Textile Care Division provides chemical laundry products and proprietary dispensing systems, as well as related programs, to large industrial and commercial laundries. Typically these customers process a minimum of 1,000,000 pounds of linen each year and include free-standing laundry plants used by institutions such as hotels, restaurants and healthcare facilities as well as industrial and textile rental laundries. Products and programs include laundry cleaning and specialty products, related dispensing equipment, plus water and energy management which are marketed primarily through a Company-employed sales force and, to a lesser extent, through independent, third-party distributors. The Division’s programs are designed to meet our customer’s need for exceptional cleaning, while extending the useful life of linen and reducing the customer’s overall operating cost.

**Healthcare**** : Our Healthcare Division provides infection prevention and healthcare offerings to hospital, acute care and long-term care markets in the United States. Healthcare’s proprietary infection prevention/healthcare products (skin care, disinfectants and instrument cleaners) are sold primarily under the “Ecolab”, “Huntington” and “Microtek” brand names.

**Vehicle Care** : Our Vehicle Care Division provides vehicle appearance products which include soaps, polishes, sealants, wheel and tire treatments and air fresheners. Products are sold to vehicle rental, fleet and consumer car wash and detail operations. Brand names utilized by the Vehicle Care Division include Blue Coral Ò , Black Magic Ò and Rain-X Ò .

**Water Care Services**** : Water Care Services provides water and wastewater treatment products, services and systems for commercial/institutional customers (full service hotels, cruise ships, hospitals, healthcare, commercial real estate, government, and commercial laundries), food and beverage customers (dairies, meat, poultry, food processing and beverage) and other light industry. Water Care Services works closely with our Institutional, Textile Care and Food & Beverage Divisions to offer customized water care strategies to their accounts that have water care needs, primarily to treat water used in heating and cooling systems and manufacturing processes and to treat wastewater.

*United States Other Services Segment*

The “United States Other Services” segment is comprised of two business units: Pest Elimination and GCS Service. In general, these businesses provide service or equipment which can augment or extend our product offering to our business customers as a part of our “Circle the Customer” approach.

**Pest Elimination**** : Our Pest Elimination Division provides services for the detection, elimination and prevention of pests to restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick-service restaurant and grocery operations and other institutional and commercial customers. These services are sold and performed by Company-employed sales and service personnel. In addition, through our EcoSure Food Safety Management business, we provide customized on-site evaluations, training and quality assurance services to foodservice operations.

**GCS Service**** : GCS Service provides commercial cooking and refrigeration equipment repair and maintenance services for restaurant and other foodservice operations. Repair services are offered for in-warranty repair, acting as the Manufacturer’s Authorized Service Agent, as well as after warranty repair. In addition, GCS Service operates as a parts distributor to repair service companies and end users.

*International Segment*

We conduct business in approximately 70 countries outside of the United States through wholly-owned subsidiaries or, in the case of Israel and Venezuela, through joint ventures with local partners. In other countries, selected products are sold by our export operations to distributors, agents or licensees, although the volume of those sales is not significant in terms of our overall revenues. Our largest International operations are located in Europe, Asia Pacific, Latin America

5

SEQ.=1,FOLIO='5',FILE='C:\JMS\mvreela\08-6080-1\task2713946\6080-1-ba-01.htm',USER='mvreela',CD='Feb 21 19:48 2008'

and Canada, with smaller operations in Africa and the Middle East.

In general, the businesses conducted internationally are similar to those conducted in the United States but are managed on a geographic basis. The businesses which are similar to the United States’ Institutional and Food & Beverage businesses are the largest businesses in our International operations. They are conducted in virtually all our International locations and, compared to the United States, constitute a larger portion of the overall business. Kay also has sales in a number of International locations. A significant portion of Kay’s international sales are to international units of United States-based quick-service restaurant chains. Consequently, a substantial portion of Kay’s international sales are made either to domestic or internationally-located third-party distributors who serve these chains.

Our Pest Elimination business continues to expand its geographic coverage. Since 2001, we have entered markets in Asia, Western Europe and Latin America, with the largest operations in France and the United Kingdom.

Our other businesses are conducted less extensively in our International locations. However, in general, most of the principal businesses conducted in the United States are operated in Canada.

International businesses are subject to the usual risks of foreign operations, including possible changes in trade and foreign investment laws, tax laws, currency exchange rates and economic and political conditions abroad. The profitability of our International operations has historically been lower than the profitability of our businesses in the United States. This has been due to the smaller scale of the International operations as well as the additional cost of operating in numerous and diverse foreign jurisdictions.

*Additional Information*

**Competition**** : Our business units have two significant classes of competitors. First, each business unit competes with a small number of large companies selling directly or through distributors on a national or international scale. Second, all of our business units have numerous smaller regional or local competitors which focus on more limited geographies, product lines and/or end-user segments.

Our objective is to achieve a significant presence in each of our business markets. In general, competition is based on customer support, product performance and price. We believe we compete principally by providing superior value, premium customer support and differentiated products to help our customer protect its brand reputation. Value is provided by state-of-the-art cleaning, sanitation and maintenance products and systems coupled with high customer support standards and continuing dedication to customer satisfaction. This is made possible, in part, by our significant on-going investment in training and technology and by our standard practice of advising customers on means to lower operating costs and helping them comply with safety, environmental and sanitation regulations. In addition, we emphasize our ability to uniformly provide a variety of related premium cleaning and sanitation programs to our customers and to provide that level of customer support to multiple locations of chain customer organizations worldwide. This approach is succinctly stated in our “Circle the Customer - Circle the Globe” strategy which is discussed above in this Item 1(c) under the heading “General.”

**Sales**** : Products, systems and services are primarily marketed in domestic and international markets by Company-trained sales personnel who also advise and assist our customers in the proper and efficient use of the products and systems in order to meet a full range of cleaning and sanitation needs. Independent, third-party distributors are utilized in several markets, as described in the business unit descriptions found under the discussion of the three reportable segments above.

**Number of Employees**** : We have approximately 26,050 employees.

6

SEQ.=1,FOLIO='6',FILE='C:\JMS\mvreela\08-6080-1\task2713946\6080-1-ba-01.htm',USER='mvreela',CD='Feb 21 19:48 2008'

**Customers and Classes of Products**** : We believe that our business is not materially dependent upon a single customer although, as described above in this Item 1(c) under the description of the Kay business, Kay is largely dependent upon a limited number of national and international quick-service chains and franchisees. Additionally, although we have a diverse customer base and no customer or distributor constitutes 10 percent or more of our consolidated revenues, we do have customers and independent, third-party distributors, the loss of which could have a material negative effect on results of operations for the affected earnings periods; however, we consider it unlikely that such an event would have a material adverse impact on our financial position. No material part of our business is subject to renegotiation or termination at the election of a governmental unit. We sell two classes of products which each constitute 10 percent or more of our sales. Sales of warewashing products in 2007, 2006 and 2005 approximated 22, 21 and 21 percent, respectively, of our consolidated net sales. In addition, through our Institutional and Textile Care businesses, we sell laundry products and provide customer support to a broad range of laundry customers. Sales of laundry products and services in 2007, 2006 and 2005 approximated 10, 10 and 11 percent, respectively, of our consolidated net sales.

**Patents and Trademarks**** : We own and license a number of patents, trademarks and other intellectual property, including through a license agreement with Henkel KGaA. While we have an active program to protect our intellectual property by filing for patents or trademarks, and pursuing legal action, when appropriate, to prevent infringement, we do not believe that our overall business is materially dependent on any individual patent or trademark.

**Seasonality**** : Overall our business does not have a significant degree of seasonality. However, we do experience variability in our quarterly operating results due to sales volume and business mix fluctuations in our operating segments. Note 17, entitled “Quarterly Financial Data” located on page 47 of the Annual Report, is incorporated herein by reference.

**Working Capital**** : We have invested in the past, and will continue to invest in the future, in merchandising equipment consisting primarily of systems used by customers to dispense our cleaning and sanitizing products. Otherwise, we have no unusual working capital requirements.

**Manufacturing and Distribution**** : We manufacture most of our products and related equipment in Company-owned manufacturing facilities. Some products are also produced for us by third-party contract manufacturers, including Henkel KGaA. Other products and equipment are purchased from third-party suppliers. Additional information on product/equipment sourcing is found in the segment discussions above and additional information on our manufacturing facilities is located beginning at page 16 of this Form 10-K under the heading “Properties.”

Deliveries to customers are made from our manufacturing plants and a network of distribution centers and public warehouses. We use common carriers, our own delivery vehicles, and distributors. Additional information on our plant and distribution facilities is located beginning at page16 of this Form 10-K under the heading “Properties.”

**Raw Materials**** : Raw materials purchased for use in manufacturing our products are inorganic chemicals, including alkalis, acids, phosphates, silicates and salts, and organic chemicals, including surfactants and solvents. These materials are generally purchased on an annual contract basis from a diverse group of chemical manufacturers. When practical, global sourcing is used so that purchasing or production locations can be shifted to control product costs at globally competitive levels. Pesticides used by our Pest Elimination Division are purchased as finished products under contract or purchase order from the producers or their distributors. We also purchase packaging materials for our manufactured products and components for our specialized cleaning equipment and systems. Most raw materials, or substitutes for those materials, used by us, with the exception of a few specialized chemicals which we manufacture, are available from several suppliers.

7

SEQ.=1,FOLIO='7',FILE='C:\JMS\mvreela\08-6080-1\task2713946\6080-1-ba-01.htm',USER='mvreela',CD='Feb 21 19:48 2008'

**Research and Development**** : Our research and development program consists principally of devising and testing new products, processes, techniques and equipment, improving the efficiency of existing ones, improving service program content, and evaluating the environmental compatibility of products. Key disciplines include analytical and formulation chemistry, microbiology, process and packaging engineering and product dispensing technology. Substantially all of our principal products have been developed by our research, development and engineering personnel. At times, technology has also been licensed from third parties to develop offerings. Note 13, entitled “Research Expenditures” located on page 41 of the Annual Report, is incorporated herein by reference.

**Environmental and Regulatory Considerations**** : Our businesses are subject to various legislative enactments and regulations relating to the protection of the environment and public health. While we cooperate with governmental authorities and take commercially practicable measures to meet regulatory requirements and avoid or limit environmental effects, some risks are inherent in our businesses. Among the risks are costs associated with transporting and managing hazardous substances, waste disposal and plant site clean-up, fines and penalties if we are found to be in violation of law, as well as modifications, disruptions or discontinuation of certain operations or types of operations including product recalls and reformulations. Additionally, although we are not currently aware of any such circumstances, there can be no assurance that future legislation or enforcement policies will not have a material adverse effect on our consolidated results of operations, financial position or cash flows. Environmental and regulatory matters most significant to us are discussed below.

*Ingredient Legislation* : Various laws and regulations have been enacted by state, local and foreign jurisdictions pertaining to the sale of products which contain phosphorous, volatile organic compounds, or other ingredients that may impact human health or the environment. Under California Proposition 65, label disclosures are required for certain products containing chemicals listed by California. “Green” chemistry initiatives that promote pollution prevention through research and development of safer chemicals and safer chemical processes are being advanced by certain states, including California, Maine, Massachusetts and Vermont. To date, we generally have been able to comply with such legislative requirements by reformulation or labeling modifications. Such legislation has not had a material negative effect on our consolidated results of operations, financial position or cash flows to date.

*Pesticide Legislation* : Various international, federal and state environmental laws and regulations govern the manufacture and/or use of pesticides. We manufacture and sell certain disinfecting and sanitizing products which kill or reduce microorganisms (bacteria, viruses, fungi) on hard environmental surfaces and on certain food products. Such products constitute “pesticides” or “antimicrobial pesticides” under the current definitions of the Federal Insecticide Fungicide and Rodenticide Act (“FIFRA”), as amended by the Food Quality Protection Act of 1996, the principal federal statute governing the manufacture, labeling, handling and use of pesticides. We maintain approximately 350 product registrations with the U.S. Environmental Protection Agency (“EPA”). Registration entails the necessity to meet certain efficacy, toxicity and labeling requirements and to pay on-going registration fees. In addition, each state in which these products are sold requires registration and payment of a fee. In general, the states impose no substantive requirements different from those required by FIFRA. However, California and certain other states have adopted additional regulatory programs, and California imposes a tax on total pesticide sales in that State. While the cost of complying with rules as to pesticides has not had a material adverse effect on our consolidated results of operations, financial condition, or cash flows to date, the costs and delays in receiving necessary approvals for these products continue to increase. Total fees paid to the EPA and the states to obtain or maintain pesticide registrations, and for the California tax, were approximately $2,800,000 in 2007 and $3,400,000 in 2006. In Europe, the Biocidal Product Directive (98/8/EC) (“BPD”) established a program to evaluate and authorize marketing of biocidal active substances and products. We are working with suppliers and industry

8

SEQ.=1,FOLIO='8',FILE='C:\JMS\mvreela\08-6080-1\task2713946\6080-1-ba-01.htm',USER='mvreela',CD='Feb 21 19:48 2008'

groups to manage requirements associated with the BPD, and have met the first relevant deadline of the program by the timely submission of dossiers for active substances. Anticipated registration costs are not expected to significantly affect our consolidated results of operations, financial position or cash flows.

In addition, our Pest Elimination Division applies restricted-use pesticides which it generally purchases from third parties. That Division must comply with certain standards pertaining to the use of such pesticides and to the licensing of employees who apply such pesticides. Such regulations are enforced primarily by the states or local jurisdictions in conformity with federal regulations. We have not experienced material difficulties in complying with these requirements.

*FDA Antimicrobial Product Requirements* : Various laws and regulations have been enacted by federal, state, local and foreign jurisdictions regulating certain products manufactured and sold by us for controlling microbial growth on humans, animals, foods and medical devices. In the United States, these requirements generally are administered by the U.S. Food and Drug Administration (“FDA”). However, the U.S. Department of Agriculture and EPA also may share in regulatory jurisdiction of antimicrobials applied to food. The FDA also has been expanding requirements applicable to such products, including proposing regulations in a Tentative Final Monograph for Healthcare Antiseptic Drug Products dated June 17, 1994, which may impose additional requirements associated with antimicrobial hand care products and associated costs when finalized by the FDA. To date, such requirements have not had a material adverse effect on our consolidated results of operations, financial position or cash flows.

*Europe* : The European Union is developing a new regulatory framework for the Registration, Evaluation and Authorization of Chemicals (REACH). The European Parliament and Council adopted the REACH regulation in December 2006, which became effective in June 2007. It established a new European Chemicals Agency in Helsinki, Finland, which is responsible for evaluating data to determine hazards and risks and to manage this program for authorizing chemicals for sale and distribution in Europe. All “new” and “existing” chemicals produced or imported into the European Union in quantities above one ton per year must be registered in a central database. For chemicals deemed to be of most concern, industry must gain specific authorization for particular uses which have been demonstrated to be safe. Other uses would be prohibited. To manage this new program, we are simplifying our product line and working with chemical suppliers to comply with registration requirements. The eventual impact of REACH will also be felt by our competitors. Potential costs to us are not yet fully quantifiable, but are not expected to significantly affect our consolidated results of operations, financial position or cash flows.

In 2003, the United Nations issued a standard on hazard communication and labeling of chemical products known as the Globally Harmonized System of Classification and Labeling of Chemicals (“GHS”). GHS is designed to facilitate international trade and increase safe handling and use of hazardous chemicals through a worldwide, uniform system that classifies chemicals based on their intrinsic hazards and communicates information about those hazards through standardized safety labeling and safety warnings. Individual countries and regional organizations either have begun to implement GHS or are considering what portions of it will be adopted and within what timeframe. Most countries in which we operate will adopt GHS-related legislation. The primary cost of compliance will revolve around labeling, and we are working toward a phased-in approach to mitigate risks of GHS implementation. Potential costs to us are not yet fully quantifiable but are not expected to have a material adverse effect on our consolidated results of operations, financial position or cash flows.

9

SEQ.=1,FOLIO='9',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-03.htm',USER='cjensena',CD='Feb 25 11:07 2008'

*Other Environmental Legislation* : Our manufacturing plants are subject to federal, state, local or foreign jurisdiction laws and regulations relating to discharge of hazardous substances into the environment and to the transportation, handling and disposal of such substances. The primary federal statutes that apply to our activities are the Clean Air Act, the Clean Water Act and the Resource Conservation and Recovery Act. We are also subject to the Superfund Amendments and Reauthorization Act of 1986, which imposes certain reporting requirements as to emissions of hazardous substances into the air, land and water. We make capital investments and expenditures to comply with environmental laws and regulations, to ensure employee safety and to carry out our announced environmental sustainability principles. To date, such expenditures have not had a significant adverse effect on our consolidated results of operations, financial position or cash flows. Our capital expenditures for environmental health and safety projects worldwide were approximately $8,100,000 in 2007 and $6,400,000 in 2006. Approximately $7,800,000 has been budgeted globally for projects in 2008.

*Climate Change* : Various laws and regulations pertaining to climate change have been implemented or are being considered for implementation at the international, national, regional and state levels, particularly as they relate to the reduction of greenhouse gas (GHG) emissions. None of these laws and regulations directly applies to Ecolab at the present time, however, as a matter of corporate policy, Ecolab supports a balanced approach to reducing GHG emissions while sustaining economic growth and competitiveness. Ecolab has joined U.S. EPA’s Climate Leaders program, and as part of that program we have pledged to develop a corporate-wide U.S. GHG emission inventory and work with EPA to set a GHG reduction goal in 2008.

*Environmental Remediation and Proceedings* : Along with numerous other potentially responsible parties (“PRPs”), we are currently involved with waste disposal site clean-up activities imposed by the federal Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA”) or state equivalents at 19 sites in the United States. Additionally, we have similar liability at nine sites outside the United States. In general, under CERCLA, we and each other PRP that actually contributes hazardous substances to a Superfund site are jointly and severally liable for the costs associated with cleaning up the site. Customarily, the PRPs will work with the EPA to agree and implement a plan for site remediation. Pursuant to an Environmental Agreement dated December 7, 2000 with Henkel KGaA, Henkel agreed to indemnify us for certain environmental liabilities associated with the parties’ former joint venture in Europe. We received euro 626,763 (approximately $917,000) from Henkel in 2007 for such environmental liabilities and we recently requested an additional euro 203,890 (approximately $300,000 at December 31, 2007) for new environmental costs.

Based on an analysis of our experience with such environmental proceedings, our estimated share of all hazardous materials deposited on the sites referred to in the preceding paragraph, and our estimate of the contribution to be made by other PRPs which we believe have the financial ability to pay their shares, we have accrued our best estimate of our probable future costs relating to such known sites. Unasserted claims are not reflected in the accrual. In establishing accruals, potential insurance reimbursements are not included. The accrual is not discounted. It is not feasible to predict when the amounts accrued will be paid due to the uncertainties inherent in the environmental remediation and associated regulatory processes.

10

SEQ.=1,FOLIO='10',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-03.htm',USER='cjensena',CD='Feb 25 11:07 2008'

Our worldwide net expenditures for contamination remediation were approximately $1,060,000 in 2007 and $950,000 in 2006. Including the ChemLawn matters described below, our worldwide accruals at December 31, 2007 for probable future remediation expenditures totaled approximately $3,990,000. We review our exposure for contamination remediation costs periodically and our accruals are adjusted as considered appropriate. While the final resolution of these issues could result in costs below or above current accruals and, therefore, have an impact on our consolidated financial results in a future reporting period, we believe the ultimate resolution of these matters will not have a material effect on our consolidated results of operations, financial condition or liquidity. In addition, we have retained responsibility for certain sites where our former ChemLawn business is a PRP. Currently there are five such locations and, at each, ChemLawn is a de minimis party. Anticipated costs currently accrued for these matters were included in our loss from our discontinued ChemLawn operations in 1991. The accrual remaining reflects our best estimate of probable future costs.

*Item 1(d) Financial Information About Geographic Areas* .

The financial information about geographic areas appearing under the heading “Operating Segments” in Note 16, located on pages 45 and 46 of the Annual Report, is incorporated herein by reference.

*Item 1(e) Available Information* .

Our Internet address is www.ecolab.com. Copies of our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to these reports, are available free of charge on our website at www.ecolab.com/investor as soon as reasonably practicable after such material is filed with, or furnished to, the Securities and Exchange Commission.

In addition, the following governance materials are available on our website at www.ecolab.com/investor/governance and the same information is available in print to any requesting persons, free of charge, by writing to the Corporate Secretary at our headquarters address, or by submitting an e-mail request to [email protected]: (i) charters of the Audit, Compensation, Finance and Governance Committees of our Board of Directors; (ii) our Board’s Corporate Governance Principles; and (iii) our Code of Conduct and Code of Ethics for Senior Officers and Finance Associates.

*Executive Officers of the Company*

The persons listed in the following table are our current executive officers. Officers are elected annually. There is no family relationship among any of the directors or executive officers, and no executive officer has been involved during the past five years in any legal proceedings described in applicable Securities and Exchange Commission regulations.

11

SEQ.=1,FOLIO='11',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-03.htm',USER='cjensena',CD='Feb 25 11:07 2008'

Name Age Office Positions Held Since Jan. 1, 2003
Douglas M. Baker, Jr. 49 Chairman of the Board,
President and Chief Executive Officer May 2006 – Present
President and Chief
Executive Officer Jul. 2004 –
Apr. 2006
President and Chief
Operating Officer Jan. 2003 –
Jun. 2004
Lawrence T. Bell 59 General Counsel and
Secretary Feb. 2008 –
Present
Senior Vice President,
General Counsel and Secretary Jan. 2003 –
Jan. 2008
Steven
L. Fritze 53 Chief
Financial Officer Feb. 2008 – Present
Executive
Vice President and Chief Financial Officer Feb. 2004 – Jan. 2008
Senior
Vice President and Chief Financial Officer Jan. 2003 – Jan. 2004
Robert K. Gifford 50 Senior Vice President –
Global Supply Chain Oct. 2005 –
Present
Vice President – Supply
Chain Management Sep. 2004 –
Sep. 2005 (1)
Thomas W. Handley 53 President – Industrial
and Services North America Sector Dec. 2007 –
Present
Executive Vice
President – Industrial Sector Apr. 2006 –
Nov. 2007
Executive Vice
President – Specialty Sector Jan. 2004 –
Mar. 2006
Senior Vice President –
Strategic Planning Aug. 2003 –
Dec. 2003 (2)
Michael A.
Hickey 46 Senior Vice
President – Global Business Development Jan. 2006 –
Present
Senior Vice
President – Global / Corporate Accounts Nov. 2005 –
Dec. 2005
Vice President –
Global/Corporate Accounts, Institutional Division Jan. 2003 –
Oct. 2005
Phillip J. Mason 57 President –
International Sector Dec. 2007 –
Present

12

SEQ.=1,FOLIO='12',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-03.htm',USER='cjensena',CD='Feb 25 11:07 2008'

Name Age Office Positions Held Since Jan. 1, 2003
Phillip J. Mason (con’t.) Executive Vice
President – Asia Pacific and Latin America Dec. 2004 –
Nov. 2007
Senior Vice President –
Strategic Business Development May 2004 –
Nov. 2004 (3)
Michael L. Meyer 50 Senior Vice
President-Human Resources Feb. 2008 –
Present (4)
James A. Miller 51 President –
Institutional North America Sector Dec. 2007 –
Present
Executive Vice
President – Institutional Sector North America Jan. 2004 –
Nov. 2007
Vice President and
General Manager – Institutional Jan. 2003 –
Dec. 2003
Susan K. Nestegard 47 Senior Vice President –
Research, Development and Engineering and Chief Technical Officer Dec. 2004 –
Present
Vice President –
Research, Development and Engineering and Chief Technical Officer Mar. 2003 –
Nov. 2004 (5)
Daniel J. Schmechel 48 Senior Vice President
and Controller Dec. 2005 –
Present
Vice President and
Controller Jan. 2003 –
Nov. 2005
Robert P. Tabb 57 Vice President and
Chief Information Officer Sep. 2003 –
Present (6)
James H. White 43 President-EMEA Sector Dec. 2007 – Present
Executive Vice
President – EMEA Apr. 2007 –
Nov. 2007
Senior Vice President –
Strategy and Marketing Development May 2006 –
Mar. 2007
Senior Vice President –
Strategic Planning Oct. 2005 –
Apr. 2006 (7)

(1) Prior to joining Ecolab in 2004, Mr. Gifford served as Vice President, World Logistics and Program Manager of Hewlett Packard Corporation for three years. Prior to Hewlett Packard, Mr. Gifford was employed by Compaq and Tandem.

(2) Prior to joining Ecolab in 2003, Mr. Handley was employed by the Procter & Gamble Company for 22 years in various management, marketing and executive positions including assignments in Japan and Mexico. Mr. Handley’s last position at P&G was Vice President - Feminine Care Strategic Planning.

(3) Mr. Mason re-joined Ecolab in 2004, where he formerly served 23 years in various management and executive positions, most recently as Vice President – Asia Pacific. Prior to re-joining Ecolab, Mr. Mason was employed by HAVI Group, LP, serving as President, HPR Partners from 1997-2004.

(4) Prior to joining Ecolab in February 2008, Mr. Meyer was employed for 24 years by Abbott Laboratories, most recently as Vice President Vascular Business Latin America and Canada. Mr. Meyer’s management and executive experience includes 22 years in Human Resources and assignments in Canada and Hong Kong.

13

SEQ.=1,FOLIO='13',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-03.htm',USER='cjensena',CD='Feb 25 11:07 2008'

(5) Prior to joining Ecolab in March 2003, Ms. Nestegard was employed by 3M Company for 20 years, most recently as Business Director of Optical Components. Ms. Nestegard’s experience includes product and process development and technical management as Director Engineering Systems Technology Center and as Technical Director of the Electronic Products Division of 3M in Austin, Texas.

(6) Prior to joining Ecolab in September 2003, Mr. Tabb held various executive positions in the systems technology industry, most recently with Focus IT Group, a consulting firm. From 2000 – 2001 Mr. Tabb served as Vice President, Global Information Technology at Nike, Inc. From 1997 – 2000 Mr. Tabb was employed by CNF Transportation, Inc. as Vice President and Chief Information Officer.

(7) Prior to joining Ecolab in 2005, Mr. White was employed by International Multifoods, and served as President of its U.S. Consumer Products Division. Mr. White’s employment also includes marketing experience at General Mills, and nine years at the Pillsbury Company in a succession of management positions.

*Item 1A. Risk Factors* .

The following are important factors which could affect our financial performance and could cause our actual results for future periods to differ materially from our anticipated results or other expectations, including those expressed in any forward-looking statements made in this Form 10-K. See the section entitled Forward-Looking Statements located on page 2 of this Form 10-K.

We may also refer to this disclosure to identify factors that may cause results to differ from those expressed in other forward-looking statements made in oral presentations, including telephone conference and/or webcasts open to the public.

Except as may be required under applicable law, we undertake no duty to update our Forward-Looking Statements.

*Our results depend upon the continued vitality of the markets we serve:* Economic downturns, and in particular downturns in the foodservice, hospitality, travel, health care and food processing industries, can adversely impact our end-users who are sensitive to changes in travel and dining activities. During such downturns, these end-users typically reduce their volume of purchases of cleaning, hygiene and appearance products, which would likely in turn have an adverse impact on our consolidated results of operations, financial condition, or cas h flows.

*Our growth depends upon our ability to successfully compete with respect to value, product offerings and customer support:* Our competitive market is made up of numerous national, regional and local competitors. Our ability to compete depends in part upon our ability to maintain a superior technological capability and to continue to identify, develop and commercialize innovative, high value-added products for niche applications. There can be no assurance that we will be able to accomplish this or that technological developments by our competitors will not place certain of our products at a competitive disadvantage in the future. In addition, certain of the new products that we have under development will be offered in markets in which we do not currently compete, and there can be no assurance that we will be able to compete successfully in those new markets. If we fail to timely introduce new technologies, we may lose market share and our consolidated results of operations, financial condition, or cash flows could be adversely affected.

*We enter into multi-year contracts with customers that can impact our results:* We enter into multi-year contracts with some of our customers which include terms affecting our pricing flexibility. There can be no assurance that these restraints will not have an adverse impact on our margins and operating income.

*Consolidation of our customers and vendors can affect our results:* Customers and vendors in the foodservice, hospitality and lodging industry have been consolidating in recent years and that trend may continue. This consolidation could have an adverse impact on our ability to retain customers and on our margins and operating income.

14

SEQ.=1,FOLIO='14',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-03.htm',USER='cjensena',CD='Feb 25 11:07 2008'

*Our results can be adversely affected by fluctuations in the cost of raw materials:* The prices of raw materials used in our business can fluctuate significantly from time to time, and have increased in recent years. Changes in oil or raw material prices, unavailability of adequate and reasonably priced raw materials or substitutes for those raw materials, or the inability to obtain or renew supply agreements on favorable terms can adversely affect ou r consolidated results of operations, financial position or cash flows.

*If we are unsuccessful in integrating acquisitions, our business could be adversely affected :* As part of our long-term strategy, we seek to acquire complementary businesses. There can be no assurance that we will find attractive acquisition candidates or succeed at effectively managing the integration of acquired businesses into existing businesses. If the expected synergies from such transactions do not materialize or we fail to successfully integrate new businesses into our existing businesses, our consolidated results of operations, financial position or cash flows could be adversely affected.

*If we are unsuccessful in executing on business investments, our business could be adversely affected:* We are making investments to develop business systems and optimize our business structure as part of our ongoing efforts to improve our efficiency and returns. If the projects in which we are investing are not successfully executed, our consolidated results of operations, financial position or cash flows could be adversely affected.

*Our business depends on our ability to comply with governmental regulations:* Our business is subject to numerous regulations relating to the environment and to the manufacture, storage, distribution, sale and use of our products. Compliance with these regulations, as well as changes in tax, fiscal, governmental and other regulatory policies expose us to potential financial liability and increase our operating costs. Regulation of our products and operations continues to increase with more stringent standards, causing increased costs of operations and potential for liability if a violation occurs. The potential cost to us relating to environmental and product registration laws and regulations is uncertain due to factors such as the unknown magnitude and type of possible contamination and clean-up costs, the complexity and evolving nature of laws and regulations, and the timing and expense of compliance. In addition, changes in accounting standards, including the adoption effective January 1, 2007 of FASB Interpretation No. 48 “Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109”, could increase the volatility of our quarterly tax rate.

*Our results are impacted by general worldwide economic factors:* Economic factors such as the worldwide economy, interest rates and currency movements including, in particular, our exposure to foreign currency risk have affected our business in the past and may have a material adverse impact on our consolidated results of operations, financial condition, or cash flows in the future.

*Extraordinary events may significantly impact our business:* The occurrence of (a) litigation or claims, (b) the loss or insolvency of a major customer or distributor, (c) war (including acts of terrorism or hostilities which impact our markets), (d) natural or manmade disasters, or (e) severe weather conditions or public health epidemics affecting the foodservice, hospitality and travel industries may have a significant, adverse impact on our business.

Defense of litigation, particularly certain types of actions such as antitrust, patent infringement, wage hour and class action lawsuits, can be costly and time consuming even if ultimately successful, and if not successful could have a material adverse impact on our consolidated results of operations, financial position or cash flows.

15

SEQ.=1,FOLIO='15',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-03.htm',USER='cjensena',CD='Feb 25 11:07 2008'

While we have a diverse customer base and no customer or distributor constitutes 10 percent or more of our consolidated revenues, we do have customers and independent, third-party distributors, the loss of which could have a material negative effect on our consolidated results of operations for the affected earnings periods; however, we consider it unlikely that such an event would have a material adverse impact on our financial position.

War (including acts of terrorism or hostilities), natural or manmade disasters or severe weather conditions or public health epidemics affecting the foodservice, hospitality and travel industries cause a d ownturn in the business of restaurants, motels and hotels and other of our customers, which in turn can have a material adverse impact on our business, financial condition, results of operations and cash flows.

*We depend on key personnel to lead our business:* O ur continued success will largely depend on our ability to attract and retain a high caliber of talent and on the efforts and abilities of our executive officers and certain other key employees. Our operations could be adversely affected if for any reason such officers or key employees did not remain with us.

*Item 1B. Unresolved Staff Comments* .

We have no unresolved comments from the staff of the Securities and Exchange Commission.

*Item 2. Properties* .

Our manufacturing philosophy is to manufacture products wherever an economic, process or quality assurance advantage exists or where proprietary manufacturing techniques dictate internal production processes. Currently, most products sold by us are manufactured at our facilities.

Our manufacturing facilities produce chemical products or equipment for all of our businesses, although the businesses constituting the United States Other Services segment purchase the majority of their products and equipment from outside suppliers. Our chemical production process consists primarily of blending and packaging powders and liquids and casting solids. Our equipment manufacturing operations consist primarily of producing chemical product dispensers and injectors and other mechanical equipment and dishwasher racks and related sundries.

The following chart profiles our main manufacturing facilities with ongoing production activities. In general, manufacturing facilities located in the United States serve the “United States Cleaning & Sanitizing” segment and facilities located outside of the United States serve the “International” segment. However, certain of the United States facilities do manufacture products for export and which are used by the International segment. The facilities having export involvement are marked with an asterisk (*).

16

SEQ.=1,FOLIO='16',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-03.htm',USER='cjensena',CD='Feb 25 11:07 2008'

*ECOLAB OPERATIONS PLANT PROFILES*

Location Size (Sq. Ft.) Types of Products Majority Owned or Leased
UNITED STATES
Joliet, IL* 610,000 Solids, Liquids, Powders Owned
South Beloit, IL* 313,000 Equipment Owned
Garland, TX* 239,000 Solids, Liquids Owned
Martinsburg, WV 228,000 Liquids Owned
Hebron, OH 196,000 Liquids Owned
Greensboro, NC 193,000 Liquids, Powders Owned
San Jose, CA 175,000 Liquids Owned
McDonough, GA* 141,000 Solids, Liquids Owned
Eagan, MN* 133,000 Solids, Liquids, Emulsions, Powders Owned
Huntington, IN* 127,000 Liquids Owned
City of Industry, CA 125,000 Liquids Owned
Elk Grove Village, IL* 115,000 Equipment Leased
Fort Worth, TX 101,000 Equipment Leased
Jacksonville, FL* 88,000 Medical Devices Leased
Carrollton, TX 70,000 Liquids Owned
Tyler, TX* 63,000 Medical Devices Leased
Columbus, MS 49,000 Medical Devices Owned
St. Louis, MO 37,000 Equipment Leased
INTERNATIONAL
Chalons, FRANCE 280,000 Liquids, Powders Owned
Nieuwegein, NETHERLANDS 168,000 Powders Owned
La Romana, DOMINICAN REPUBLIC 160,000 Medical Devices Leased
Tessenderlo, BELGIUM 153,000 Solids, Liquids Owned
Melbourne, AUSTRALIA 145,300 Liquids, Powders Owned
Rozzano, ITALY 126,000 Liquids Owned
Mississauga, CANADA 120,400 Liquids Leased
Johannesburg, SOUTH AFRICA 100,000 Liquids, Powders Owned
Hamilton, NEW ZEALAND 96,000 Solids, Liquids, Powders Owned
Mullingar, IRELAND 74,300 Liquids Leased
Mosta, MALTA 73,000 Medical Devices Leased
Valby, DENMARK 70,000 Liquids Owned
Sao Paulo, BRAZIL 62,325 Solids, Liquids Leased
Shika, JAPAN 60,000 Liquids Owned
Santiago, CHILE 60,000 Liquids, Powders Leased
Revesby, AUSTRALIA 59,200 Liquids, Powders Owned
Cheadle (Hulme), UNITED KINGDOM 52,575 Liquids Leased

17

SEQ.=1,FOLIO='17',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-03.htm',USER='cjensena',CD='Feb 25 11:07 2008'

Location Size (Sq. Ft.) Types of Products Majority Owned or Leased
Guangzhou, CHINA 50,230 Liquids, Powders Leased
Noda, JAPAN 49,000 Solids, Liquids, Powders Owned
Siegsdorf,
GERMANY 42,000 Equipment Owned
Zutphen,
NETHERLANDS 41,000 Medical Devices Leased
Mexico City,
MEXICO 40,000 Liquids, Powders Owned
Maribor,
SLOVENIA 39,000 Liquids, Powders Owned
Leeds, UNITED
KINGDOM 35,000 Liquids Owned
Pilar, ARGENTINA 30,000 Liquids, Powders Owned
Shanghai, CHINA 27,000 Solids, Liquids, Powders Owned
Perth, AUSTRALIA 26,900 Liquids, Powders Owned
Dorado, PUERTO
RICO 25,000 Liquids, Powders Leased
Singapore,
SINGAPORE 25,000 Liquids, Powders Owned
Dar es Salaam,
TANZANIA 22,900 Liquids, Powders Leased
Seoul, SOUTH
KOREA 22,160 Liquids, Powders Owned
Racibor, POLAND 20,000 Liquids Leased
Toulon, FRANCE 20,000 Medical Devices Leased
Mandras, GREECE 18,000 Liquids Owned
Varssesveld,
NETHERLANDS 17,000 Medical Devices Leased
San Jose, COSTA
RICA 11,000 Liquids, Powders Owned
Bogota, COLOMBIA 11,000 Liquids Leased
Cikarang,
INDONESIA 10,000 Solids, Liquids, Powders Owned
Bangkok,
THAILAND 10,000 Liquids, Powders Owned
Manilla,
PHILIPPINES 7,600 Liquids, Powders Owned

We believe our manufacturing facilities are in good condition and are adequate to meet our existing production needs. A new manufacturing facility in Wales, U.K. is nearing completion.

Most of our manufacturing plants also serve as distribution centers. In addition, we operate distribution centers around the world, all of which are leased, and utilize various public warehouses to facilitate the distribution of our products and services. In the United States, our sales and service associates are located in approximately 90 leased offices. Additional sales offices are located internationally.

Our corporate headquarters is comprised of three adjacent multi-storied buildings located in downtown St. Paul, Minnesota. The main 19-story building was constructed to our specifications and is leased through 2013. Thereafter, it is subject to multiple renewals at our option. The second building is leased through 2011 with additional options available. The third building is owned. The corporate headquarters includes an employee training center. In April 2004, we purchased a 90 acre campus in Eagan, Minnesota to provide for future growth. The acquired facility houses the research and development and data center requirements as well as several of our administrative functions. Renovations of the buildings on this property, comprising approximately 500,000 square feet, have been completed and more than 900 associates now work at this site.

18

SEQ.=1,FOLIO='18',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-03.htm',USER='cjensena',CD='Feb 25 11:07 2008'

*Item 3. Legal Proceedings* .

Note 14, entitled “Commitments and Contingencies” located on page 41 of the Annual Report, is incorporated herein by reference.

Other matters arising under laws relating to protection of the environment are discussed at Item 1(c) above, under the heading “Environmental and Regulatory Considerations.”

*Item 4. Submission of Matters to a Vote of Security Holders* .

No matters were submitted to a vote of our security holders during the fourth quarter of 2007.

*PART II*

*Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities* .

**Market Information**** : Our Common Stock is listed on the New York Stock Exchange under the symbol “ECL.” The Common Stock is also traded on an unlisted basis on certain other United States exchanges. The high and low sales prices of our Common Stock on the consolidated transaction reporting system during 2007 and 2006 were as follows:

Quarter 2007 — High Low 2006 — High Low
First $ 45.37 $ 37.01 $ 40.50 $ 33.64
Second $ 44.79 $ 41.12 $ 41.20 $ 37.00
Third $ 47.59 $ 39.01 $ 45.44 $ 39.57
Fourth $ 52.78 $ 44.82 $ 46.40 $ 42.17

The closing Common Stock price on January 31, 2008 was $48.14.

**Holders**** : On January 31, 2008, we had 5,167 holders of Common Stock of record.

**Dividends**** : We have paid Common Stock dividends for 71 consecutive years. Quarterly cash dividends of $0.10 per share were declared in February, May and August 2006. Cash dividends of $0.115 per share were declared in December 2006, and February, May and August 2007. A dividend of $0.13 per share was declared in December 2007.

19

SEQ.=1,FOLIO='19',FILE='C:\JMS\ckong\08-6080-1\task2718413\6080-1-ba-05.htm',USER='ckong',CD='Feb 22 20:29 2008'

**Issuer Purchases of Equity Securities**** :

Period (a) Total number of shares purchased (1) (b) Average price paid per share (2) (c) Number of shares purchased as part of publicly announced plans or programs(3) (d) Maximum number of shares that may yet be purchased under the plans or programs(3)
October 1-31,
2007 9,209 $ 46.8075 0 4,711,600
November 1-30,
2007 12,318 $ 46.5698 0 4,711,600
December 1-31,
2007 114,547 $ 51.3961 0 4,711,600
Total 136,074 $ 50.6487 0 4,711,600

(1) Represents 136,074 shares reacquired from employees and/or directors as swaps for the cost of stock options, or shares surrendered to satisfy minimum statutory tax obligations under our stock incentive plans.

(2) The average price paid per share includes brokerage commissions associated with publicly announced plan purchases plus the value of such other reacquired shares.

(3) As announced on October 26, 2006, our Board of Directors authorized the repurchase of up to 10,000,000 shares of Common Stock, including shares to be repurchased under Rule 10b5-1. We intend to repurchase all shares under this authorization, for which no expiration date has been established, in open market or privately negotiated transactions, subject to market conditions.

*Item 6. Selected Financial Data* .

The comparative data for the years ended December 31, 2007, 2006, 2005, 2004 and 2003 inclusive, which are set forth under the heading entitled “Summary Operating and Financial Data” located on pages 50 and 51 of the Annual Report, are incorporated herein by reference.

*Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operation* .

The material appearing under the heading entitled “Financial Discussion,” located on pages 19 through 27 of the Annual Report, is incorporated herein by reference.

*Item 7A. Quantitative and Qualitative Disclosures about Market Risk* .

The material appearing under the heading entitled “Market Risk,” located on page 27 of the Annual Report, is incorporated herein by reference.

*Item 8. Financial Statements and Supplementary Data* .

The financial statements and material which are an integral part of the financial statements listed under Item 15(a)(1) below and located on pages 28 through 51 of the Annual Report, are incorporated herein by reference.

*Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure* .

None.

20

SEQ.=1,FOLIO='20',FILE='C:\JMS\ckong\08-6080-1\task2718413\6080-1-ba-05.htm',USER='ckong',CD='Feb 22 20:29 2008'

*Item 9A. Controls and Procedures* .

**Disclosure Controls and Procedures** : As of December 31, 2007, we carried out an evaluation, under the supervision and with the participation of our management, including the Chairman of the Board, President and Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 as amended). Based upon that evaluation, our Chairman of the Board, President and Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures are effective.

**Internal Control Over Financial Reporting : Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Under the supervision and with the participation of our management, including our Chairman of the Board, President and Chief Executive Officer and our Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under this framework, our management concluded that our internal control over financial reporting was effective as of December 31, 2007.

The Company’s independent registered public accounting firm, PricewaterhouseCoopers LLP, has audited the effectiveness of the Company’s internal control over financial reporting as of December 31, 2007. Their report, and our management reports, can be found in our Annual Report, the relevant portion of which has been filed as Exhibit (13) to this Form 10-K and is incorporated into Item 8 of this Form 10-K.

During the period October 1 - December 31, 2007, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

*Item 9B. Other Information* .

The following disclosures would otherwise be filed on Form 8-K under the heading “Item 5.02(e) – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.”

In the paragraphs below describing certain of our executive compensation plans and programs, the “Named Executive Officers or NEOs” refer to our Principal Executive Officer and Principal Financial Officer during 2007 and the next three most-highly compensated executive officers who were serving in those capacities at December 31, 2007, and the “Committee” refers to the Compensation Committee of the Board of Directors.

**General** : The components of the overall compensation program for the Company’s executive officers include base salary, long-term incentives in the form of annual stock option awards, cash-based annual bonus incentives, participation in deferred compensation and retirement plans, and certain perquisites. Information regarding the compensation awarded to the NEOs in respect of and during the year ended December 31, 2007 will be provided in the definitive proxy statement for the Company’s 2008 annual meeting of stockholders, which is expected to be filed with the Securities and Exchange Commission on or around March 19, 2008.

**Base Salary** : For the 2008 fiscal year, base salaries for the NEOs, other than the CEO, are scheduled to increase on an annualized basis by an average of 6.2%. The salary of the CEO has been established at $1,000,000, representing an increase of $100,000 over 2007. The base salaries established for the 2008 fiscal year for the NEOs are included as a part of the Named Executive Officer Summary of Base Salary, Bonus Award Opportunities, and Executive Benefits and Perquisites filed as Exhibit (10)S to this Form 10-K and incorporated by reference herein.

21

SEQ.=1,FOLIO='21',FILE='C:\JMS\ckong\08-6080-1\task2718413\6080-1-ba-05.htm',USER='ckong',CD='Feb 22 20:29 2008'

**Establishment of 2008 Non-Equity Incentive Plan Compensation Criteria** : The Company maintains annual cash incentive programs for executives referred to as the Management Incentive Plan or MIP and Management Performance Incentive Plan or MPIP. The Company’s stockholders approved the current version of the MPIP in 2004, an annual incentive plan under which awards should qualify as performance based under Internal Revenue Code Section 162(m). On February 20, 2008, as required under the terms of the MPIP, the Committee selected the CEO and CFO and the three other NEOs to participate in the MPIP for 2008, established the 2008 performance goal based upon the performance criteria of diluted earnings per share (“EPS”), set an EPS performance target of a designated earnings per share, and a designated cash award of 300% of the base salary of each such officer for 2008 to the extent the goal is achieved. The award is subject to and interpreted in accordance with the terms and conditions of the MPIP and no amount will be paid under the MPIP unless and until the Committee has determined the extent to which the performance goal has been met and the corresponding amount of the award earned by the participant. The MPIP permits the Committee to exercise downward discretion so as to pay an amount which is less than the amount of the award earned by the participant. In applying this downward discretion, the Committee considers underlying operable metrics communicated to the participant, which are described as a part of the Named Executive Officer Summary of Base Salary, Bonus Award Opportunities, and Executive Benefits and Perquisites filed as Exhibit (10)S to this Form 10-K and incorporated by reference herein. One other NEO will participate in the MIP in 2008 and the operating metrics with respect to such NEOs’ participation are similarly included as a part of Exhibit (10)S.

The following disclosures would otherwise be filed on Form 8-K under the heading “Item 5.03 - Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.”

On February 22, 2008, Ecolab’s Board of Directors approved the following amendments to the Company’s By-Laws: (1) Article IV, Section 1 was amended to reflect that the Board may elect one or more Sector Presidents; (2) Article VII, Section 1 was amended to include the position of Sector Presidents and General Counsel among the officers entitled to sign contracts and other instruments; and (3) Article VI, Section 1 and Section 2 were amended to allow stock to be issued in book-entry form without a physical stock certificate.

*PART III*

*Item 10. Directors, Executive Officers of the Registrant and Corporate Governance* .

Information about our directors is incorporated by reference from the discussion under the heading “Proposal to Elect Directors” located in the Proxy Statement. Information about compliance with Section 16(a) of the Securities Exchange Act of 1934, as amended, is incorporated by reference from the discussion under the heading “Section 16(a) Beneficial Ownership Reporting Compliance” located in the Proxy Statement. Information about our Audit Committee, including the members of the Committee, and our Audit Committee financial experts, is incorporated by reference from the discussion under the heading “Corporate Governance,” and sub-headings “Board Committees” and “Audit Committee,” located in the Proxy Statement. Information about our Code of Conduct is incorporated by reference from the discussion under the heading “Corporate Governance Materials and Code of Conduct” located in the Proxy Statement. Information regarding our executive officers is presented under the heading “Executive Officers of the Company” in Part I on pages 11 through 14 of this Form 10-K, and is incorporated herein by reference.

22

SEQ.=1,FOLIO='22',FILE='C:\JMS\ckong\08-6080-1\task2718413\6080-1-ba-05.htm',USER='ckong',CD='Feb 22 20:29 2008'

*Item 11. Executive Compensation* .

Information appearing under the headings entitled “Executive Compensation” and “Director Compensation” located in the Proxy Statement is incorporated herein by reference. However, pursuant to Instructions to Item 407(e)(5) of Securities and Exchange Commission Regulation S-K, the material appearing under the sub-heading “Compensation Committee Report” shall not be deemed to be “filed” with the Commission, other than as provided in this Item 11.

*Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters* .

Information appearing under the heading entitled “Security Ownership” located in the Proxy Statement is incorporated herein by reference. The holdings of Henkel KGaA and Henkel Corporation are subject to certain limitations with respect to our voting securities as more fully described in our Proxy Statement under the heading “Stockholder Agreement,” and is incorporated herein by reference.

A total of 622,677 shares of Common Stock held by our directors and executive officers, some of whom may be deemed to be “affiliates” of the Company, have been excluded from the computation of market value of our Common Stock on the cover page of this Form 10-K. This total represents that portion of the shares reported as beneficially owned by our directors and executive officers as of June 30, 2007, which are actually issued and outstanding.

**Equity Compensation Plan Information** : The following table presents, as of December 31, 2007, compensation plans (including individual compensation arrangements) under which our equity securities are authorized for issuance.

| Plan Category — Equity
compensation plans approved by security holders | (a) Number of securities to be issued upon exercise of outstanding options, warrants and rights — 20,614,343 | (1)(2) | (b) Weighted average exercise price of outstanding options, warrants and rights — $ 33.57 | (2) | (c) Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) — 9,110,758 | (3) |
| --- | --- | --- | --- | --- | --- | --- |
| Equity
compensation plans not approved by security holders | -0- | | — | | -0- | |
| Total | 20,614,343 | (1)(2) | $ 33.57 | (2) | 9,110,758 | (3) |

| (1) | Includes
125,534 Common Stock equivalents under our 2001 Non-Employee Director Stock
Option and Deferred Compensation Plan. These Common Stock equivalents
represent deferred compensation earned by non-employee directors and are
excluded from the calculation of weighted average exercise price of
outstanding options, warrants and rights in column (b) of this
table. |
| --- | --- |
| (2) | Includes
4,392 shares of our Common Stock subject to stock options with a
weighted-average exercise price of $26.97, which we assumed in connection
with our acquisition of Alcide Corporation effective July 30, 2004.
These assumed options are deemed exempt from shareholder approval under
Rule 303A.08 of the New York Stock Exchange in accordance with our
notice to the NYSE dated August 18, 2004. The respective Alcide plans
were amended to prohibit future grants. |
| (3) | I ncludes 1,100,000 shares restored to
reserves as part of a refueling feature of our 2002 Stock Incentive Plan. The
refueling feature permits the restoration of shares repurchased on the open
market using proceeds from options exercised under the Plan. |

23

SEQ.=1,FOLIO='23',FILE='C:\JMS\ckong\08-6080-1\task2718413\6080-1-ba-05.htm',USER='ckong',CD='Feb 22 20:29 2008'

*Item 13. Certain Relationships and Related Transactions* .

Information appearing under the heading entitled “Director Independence Standards and Determinations” and “Related Person Transactions” located in the Proxy Statement as well as the biographical material pertaining to Messrs. Stefan Hamelmann, Kasper Rorsted and Hans Van Bylen, located in the Proxy Statement under the heading “Proposal to Elect Directors” are incorporated herein by reference.

*Item 14. Principal Accountant Fees and Services* .

Information appearing under the heading entitled “Audit Fees” located in the Proxy Statement is incorporated herein by reference.

PART IV

*Item 15. Exhibits and Financial Statement Schedules* .

| (a)(1) | The following
financial statements of the Company, included in the Annual Report, are
incorporated into Item 8 hereof. — (i) | | Consolidated Statement
of Income for the years ended December 31, 2007, 2006 and 2005, Annual
Report page 28. |
| --- | --- | --- | --- |
| | (ii) | | Consolidated Balance
Sheet at December 31, 2007 and 2006, Annual Report page 29. |
| | (iii) | | Consolidated Statement
of Cash Flows for the years ended December 31, 2007, 2006 and 2005,
Annual Report page 30. |
| | (iv ) | | Consolidated Statement
of Comprehensive Income and Shareholders’ Equity for the years ended December 31,
2007, 2006 and 2005, Annual Report page 31. |
| | (v) | | Notes to Consolidated
Financial Statements, Annual Report pages 32 through 47. |
| | (vi) | | Report of Independent
Registered Public Accounting Firm, Annual Report page 49. |
| (b)(2) | All financial
statement schedules are omitted because they are not applicable or, the
required information is shown in the consolidated financial statements or the
accompanying notes to the consolidated financial statements. All significant majority-owned
subsidiaries are included in the filed consolidated financial statements. | | |
| | The following documents
are filed as exhibits to this Report.
We will, upon request and payment of a fee not exceeding the rate at
which copies are available from the Securities and Exchange Commission,
furnish copies of any of the following exhibits to stockholders. | | |
| | (3) | A. | Restated Certificate of
Incorporation of Ecolab Inc., dated as of February 27, 2006, effective
as of March 13, 2006 – Incorporated by reference to Exhibit (3)A
of our Form 10-K Annual Report for the year ended December 31,
2005. |
| | | B. | Certificate of
Designation, Preferences and Rights of Series A Junior Participating
Preferred Stock of Ecolab Inc., dated as of February 27, 2006, effective
as of March 13, 2006 – Incorporated by reference to Exhibit (3)C
of our Form 10-K Annual Report for the year ended December 31,
2005. |
| | | C. | By-Laws, as
amended through February 22, 2008. |
| | (4) | A. | Common Stock – see
Exhibits (3)A and (3)C. |

24

SEQ.=1,FOLIO='24',FILE='C:\JMS\ckong\08-6080-1\task2718413\6080-1-ba-05.htm',USER='ckong',CD='Feb 22 20:29 2008'

| | | C. | Form of Common
Stock Certificate effective February 28, 2007 – Incorporated by
reference to Exhibit (4)B of our Form 10-K Annual Report for
the year ended December 31, 2006. — Rights Agreement, dated
as of February 24, 2006, between Ecolab Inc. and Computershare Investor
Services, LLC, as Rights Agent, which includes the following exhibits
thereto: (i) Exhibit A – Form of Certificate of
Designation, Preferences and Rights of Series A Junior Participating
Preferred Stock and (ii) Exhibit B – Form of Rights
Certificate – Incorporated by reference to Exhibit (4)C of our Form 10-K
Annual Report for the year ended December 31, 2005. |
| --- | --- | --- | --- |
| | | D. | Second Amended and
Restated Stockholder’s Agreement between Henkel KGaA and Ecolab Inc., dated November 30,
2001 – Incorporated by reference to Exhibit (4) of our Form 8-K
dated November 30, 2001. |
| | | E. | Amended and Restated
Indenture, dated as of January 9, 2001, between Ecolab Inc. and The Bank
of New York Trust Company, N.A. (as successor in interest to J. P. Morgan
Trust Company, National Association and Bank One, NA) as Trustee –
Incorporated by reference to Exhibit (4)(A) of our Current Report
on Form 8-K dated January 23, 2001. |
| | | F. | Officer’s Certificate
establishing terms and conditions of 6.875% Notes due February 1, 2011 –
Incorporated by reference to Exhibit 4(B) of our Form 8-K
dated January 23, 2001. |
| | | G. | Form of 6.875%
Note due February 2, 2011 – Incorporated by reference to Exhibit 4(c) of
our Form 8-K dated January 23, 2001. |
| | | H. | Supplemental Indenture,
dated as of February 8, 2008, between Ecolab Inc. and The Bank of New
York Trust Company, N.A., as Trustee – Incorporated by reference to Exhibit 4.2
of our Current Report on Form 8-K dated February 8, 2008. |
| | | I. | Form of 4.875%
Note due February 15, 2015 – Included in Exhibit (4)H above. |
| | | Copies of other
constituent instruments defining the rights of holders of our long-term
debt are not filed herewith, pursuant to Section (b)(4)(iii) of
Item 601 of Regulation S-K, because the aggregate amount of securities
authorized under each of such instruments is less than 10% of our total
assets on a consolidated basis. We
will, upon request by the Securities and Exchange Commission, furnish to the
Commission a copy of each such instrument. | |
| (10) | A. | (i) | Multicurrency Credit
Agreement, dated as of September 29, 1993, as amended and restated as of June
1, 2006, among Ecolab Inc., the financial institutions party thereto as Banks
from time to time, the financial institutions party thereto as Issuing Banks
from time to time, Citibank, N.A., as administrative agent for the Banks and
Issuing Banks thereunder, Citibank International PLC, as agent for the Banks
in connection with certain of the Eurocurrency Advances, and JPMorgan Chase
Bank, N.A., as syndication agent – Incorporated by reference to Exhibit
(10) of our Form 8-K dated June 1, 2006. |
| | | (ii) | Extension Confirmation
Notice, dated May 14, 2007, under the Multicurrency Credit Agreement,
dated as of September 29, 1993, as amended and restated as of June 1,
2006 – Incorporated by reference to Exhibit (10) of our Form 8-K
dated May 14, 2007. |

25

SEQ.=1,FOLIO='25',FILE='C:\JMS\ckong\08-6080-1\task2718413\6080-1-ba-05.htm',USER='ckong',CD='Feb 22 20:29 2008'

| B. | (iii) — Documents comprising
global Commercial Paper Programs | Increase of Commitments
Agreement dated as of October 29, 2007 by and among Ecolab Inc.,
Citibank, N.A., JPMorgan Chase Bank, N.A., Credit Suisse, Cayman Islands
Branch, National Association, Wells Fargo Bank, National Association, ABN
AMRO Bank N.A., Bank of America, N.A. and Barclays Bank PLC, as increasing
banks, and Citibank, N.A., as agent – Incorporated by reference to Exhibit (10) of
our Form 10-Q for the quarter ended September 30, 2007. | |
| --- | --- | --- | --- |
| | (i) | U.S. $200,000,000 Euro-Commercial
Paper Programme | |
| | | (a) | Amended and Restated
Dealer Agreement dated 2 December 2005 between Ecolab Inc. (as
Guarantor), Ecolab B.V. and Ecolab Holding GmbH (as Issuers), Ecolab Inc.,
Credit Suisse First Boston (Europe) Limited (as Arranger), and Citibank
International plc and Credit Suisse First Boston (Europe) Limited (as
Dealers) – Incorporated by reference to Exhibit (10)B(i)(a) of
our Form 10-K Annual Report for the year ended December 31,
2005. |
| | | (b) | Amended and Restated
Note Agency Agreement dated as of 2 December 2005 between Ecolab Inc.,
Ecolab B.V. and Ecolab Holding GmbH (as Issuers) and Citibank, N.A. as Issue
and Paying Agent – Incorporated by reference to Exhibit (10)B(i)(b) of
our Form 10-K Annual Report for the year ended December 31,
2005. |
| | | (c) | Deed of Covenant made
on 2 December 2005 by Ecolab Inc., Ecolab B.V. and Ecolab Holding GmbH –
Incorporated by reference to Exhibit (10)B(i)(c) of our Form 10-K
Annual Report for the year ended December 31, 2005. |
| | | (d) | Deed of Guarantee made
on 2 December 2005 – Incorporated by reference to Exhibit (10)B(i)(d) of
our Form 10-K Annual Report for the year ended December 31,
2005. |
| | (ii) | U.S. $600,000,000 U.S.
Commercial Paper Program | |
| | | (a) | Form of Commercial
Paper Dealer Agreement for 4 (2) Program. Agreements have been executed with Salomon
Smith Barney, Inc. and Banc One Capital Markets, Inc – Incorporated
by reference to Exhibit (10)A(ii)(a) of our Form 10-Q
for the quarter ended June 30, 2003. |
| | | (b) | Issuing and Paying
Agency Agreement dated as of July 10, 2000 between Ecolab Inc. and Bank
One, National Association as Issuing and Paying Agent – Incorporated by
reference to Exhibit (10)A(ii)(b) of our Form 10-Q for
the quarter ended June 30, 2003. |
| C. | (i) | Ecolab Inc. 1997 Stock
Incentive Plan, as Amended and Restated as of August 18, 2000 –
Incorporated by reference to Exhibit (10) of our Form 10-Q
for the quarter ended September 30, 2000. | |
| | (ii) | Non-Statutory
Stock Option Agreement as in effect for grants through May 12, 2000 –
Incorporated by reference to Exhibit (10)B(i) of our Form 10-Q
for the quarter ended June 30, 2004. | |
| | (iii) | Non-Statutory
Stock Option Agreement as in effect for grants beginning May 13, 2000
through May 10, 2002 – Incorporated by reference to Exhibit (10)B(ii) of
our Form 10-Q for the quarter ended June 30, 2004. | |

26

SEQ.=1,FOLIO='26',FILE='C:\JMS\ckong\08-6080-1\task2718413\6080-1-ba-05.htm',USER='ckong',CD='Feb 22 20:29 2008'

| D. | (i) | 1995 Non-Employee
Director Stock Option Plan – Incorporated by reference to Exhibit (10)D(i) of
our Form 10-K Annual Report for the year ended December 31,
2006. |
| --- | --- | --- |
| | (ii) | Amendment No. 1 to
1995 Non-Employee Director Stock Option Plan effective February 25,
2000 – Incorporated by reference to Exhibit (10)E(ii) of our Form 10-K
Annual Report for the year ended December 31, 1999. |
| | (iii) | Amendment No. 2 to
1995 Non-Employee Director Stock Option Plan effective May 11,
2001 – Incorporated by reference to Exhibit (10)G(iii) of our Form 10-K
Annual Report for the year ended December 31, 2002. |
| E. | (i) | Ecolab Inc. 2001 Non-Employee
Director Stock Option and Deferred Compensation Plan as amended effective May 1,
2004 – Incorporated by reference to Exhibit (10)H(ii) of our Form 10-K
Annual Report for the year ended December 31, 2003. |
| | (ii) | Amendment No. 1
adopted December 15, 2004 to Ecolab Inc. 2001 Non-Employee
Director Stock Option and Deferred Compensation Plan, as amended and restated
effective May 1, 2004, with respect to the American Jobs Creation Act of
2004 – Incorporated by reference to Exhibit (10)F(ii) of our Form 10-K
Annual Report for the year ended December 31, 2004. |
| | (iii) | Master Agreement
Relating to Options (as in effect through May 7, 2004) –
Incorporated by reference to Exhibit (10)D(i) of our Form 10-Q
for the quarter ended June 30, 2004. |
| | (iv) | Master Agreement
Relating to Periodic Options, as amended effective as of May 1, 2004 –
Incorporated by reference to Exhibit (10)D(ii) of our Form 10-Q
for the quarter ended June 30, 2004. |
| F. | Note Purchase
Agreement, dated as of July 26, 2006 by and among Ecolab Inc. and the
Purchasers party thereto – Incorporated by reference to Exhibit (10) of
our Form 8-K dated July 26, 2006. | |
| G. | Form of Director
Indemnification Agreement.
Substantially identical agreements are in effect as to each of our
directors – Incorporated by reference to Exhibit (10)I of our Form 10-K
Annual Report for the year ended December 31, 2003. | |
| H. | (i) | Ecolab Executive Death
Benefits Plan, as amended and restated effective March 1, 1994 –
Incorporated by reference to Exhibit (10)H(i) of our Form 10-K
Annual Report for the year ended December 31, 2006. See also Exhibit (10)N
hereof. |
| | (ii) | Amendment No. 1 to
Ecolab Executive Death Benefits Plan – Incorporated by reference to Exhibit (10)H(ii) of
our Form 10-K Annual Report for the year ended December 31,
1998. |
| | (iii) | Second Declaration of
Amendment to Ecolab Executive Death Benefits Plan, effective March 1,
1998 – Incorporated by reference to Exhibit (10)H(iii) of our Form 10-K
Annual Report for the year ended December 31, 1998. |
| | (iv) | Amendment No. 3 to
the Ecolab Executive Death Benefits Plan, effective August 12, 2005 –
Incorporated by reference to Exhibit (10)B of our Form 8-K
dated December 13, 2005. |
| I. | Ecolab Executive Long-Term
Disability Plan, as amended and restated effective January 1, 1994 –
Incorporated by reference to Exhibit (10)I of our Form 10-K
Annual Report for the year ended December 31, 2004. See also Exhibit (10)N
hereof. | |

27

SEQ.=1,FOLIO='27',FILE='C:\JMS\ckong\08-6080-1\task2718413\6080-1-ba-05.htm',USER='ckong',CD='Feb 22 20:29 2008'

| J. | Ecolab Executive
Financial Counseling Plan – Incorporated by reference to Exhibit (10)J
of our Form 10-K Annual Report for the year ended December 31,
2004. | |
| --- | --- | --- |
| K. | (i) | Ecolab Supplemental
Executive Retirement Plan, as amended and restated effective January 1,
2003 – Incorporated by reference to Exhibit (10)M of our Form 10-K
Annual Report for the year ended December 31, 2003. |
| | (ii) | Amendment No. 1
and Instrument of Benefit Freeze adopted December 16, 2004 to the Ecolab
Supplemental Executive Retirement Plan (As Amended and Restated effective January 1,
2003) With Respect to the American Jobs Creation Act of 2004 –
Incorporated by reference to Exhibit (10)K(ii) of our Form 10-K
Annual Report for the year ended December 31, 2004. |
| L. | (i) | Ecolab Mirror Savings
Plan, as amended and restated effective as of March 1, 2002 –
Incorporated by reference to Exhibit (10)N of our Form 10-K
Annual Report for the year ended December 31, 2002. |
| | (ii) | Amendment No. 1
adopted December 16, 2004 to the Ecolab Mirror Savings Plan (As Amended
and Restated Effective as of March 1, 2002) With Respect to the American
Jobs Creation Act of 2004 – Incorporated by reference to Exhibit (10)L(ii) of
our Form 10-K Annual Report for the year ended December 31,
2004. |
| | (iii) | Amendment No. 2 to
the Ecolab Mirror Savings Plan, effective January 1, 2005 – Incorporated
by reference to Exhibit (10)A of our Form 8-K dated December 13,
2005. |
| M. | (i) | Ecolab Mirror Pension
Plan, as amended and restated effective as of January 1, 2003 –
Incorporated by reference to Exhibit (10)B of our Form 10-Q
for the quarter ended June 30, 2003.
See also Exhibit (10)N hereof. |
| | (ii) | Amendment No. 1
and Instrument of Benefit Freeze adopted December 16, 2004 to the Ecolab
Mirror Pension Plan (As Amended and Restated effective January 1, 2003)
With Respect to the American Jobs Creation Act of 2004 – Incorporated by
reference to Exhibit (10)M(ii) of our Form 10-K Annual
Report for the year ended December 31, 2004. |
| N. | (i) | Ecolab Inc.
Administrative Document for Non-Qualified Benefit Plans, as amended and
restated effective as of January 1, 2003 – Incorporated by
reference to Exhibit (10)P of our Form 10-K Annual Report for
the year ended December 31, 2003. |
| | (ii) | Amendment No. 1
adopted December 16, 2004 to the Ecolab Inc. Administrative Document for
Non-Qualified Benefit Plans (As Amended and Restated effective January 1,
2003) With Respect to the American Jobs Creation Act of 2004 –
Incorporated by reference to Exhibit (10)N(ii) of our Form 10-K
Annual Report for the year ended December 31, 2004. |
| O. | (i) | Ecolab Inc. Management
Performance Incentive Plan, as amended and restated on February 28, 2004 –
Incorporated by reference to Exhibit (10)A of our Form 10-Q
for the quarter ended March 31, 2004. |
| | (ii) | Amendment No. 1
adopted February 26, 2005 to the Ecolab Inc. Management Performance
Incentive Plan – Incorporated by reference to Exhibit (10)O(ii) of
our Form 10-K Annual Report for the year ended December 31,
2004. |
| P. | Ecolab Inc. Change in
Control Severance Compensation Policy, effective February 22, 2002 –
Incorporated by reference to Exhibit (10)R of our Form 10-K
Annual Report for the year ended December 31, 2001. | |

28

SEQ.=1,FOLIO='28',FILE='C:\JMS\ckong\08-6080-1\task2718413\6080-1-ba-05.htm',USER='ckong',CD='Feb 22 20:29 2008'

| | (i) | Master Agreement, dated
as of December 7, 2000, between Ecolab Inc. and Henkel KGaA –
Incorporated by reference to Exhibit 18 of HC Investments, Inc.’s
and Henkel KGaA’s Amendment No. 5 to Schedule 13D dated December 14,
2000. |
| --- | --- | --- |
| | (ii) | Amendment No. 1 to
the Master Agreement, dated December 7, 2000, between Ecolab Inc. and
Henkel KGaA – Incorporated by reference to Exhibit (10) of our
Form 10-Q for the quarter ended September 30, 2001. |
| | (iii) | Intellectual Property
Agreement dated November 30, 2001, between Ecolab and Henkel KGaA –
Incorporated by reference to Exhibit (10) of our Form 8-K
dated November 30, 2001. |
| R. | (i) | Ecolab Inc. 2002 Stock
Incentive Plan – Incorporated by reference to Exhibit (10) of
our Form 10-Q for the quarter ended June 30, 2002. |
| | (ii) | Non-statutory Stock
Option Agreement as in effect for grants beginning May 11, 2002 through August 12,
2003 – Incorporated by reference to Exhibit (10)A(i) of our Form 10-Q
for the quarter ended June 30, 2004. |
| | (iii) | Non-statutory Stock
Option Agreement as in effect for grants beginning August 13, 2003 –
Incorporated by reference to Exhibit (10)A(ii) of our Form 10-Q
for the quarter ended June 30, 2004. |
| S. | 2008 Named Executive
Officer Summary of Base Salary, Bonus Award Opportunities, and Executive
Benefits and Perquisites. | |
| T. | Non-Employee Director
Compensation and Benefits Summary. | |
| U. | (i) | Ecolab Inc. 2005 Stock
Incentive Plan – Incorporated by reference to Exhibit (10)A of our Form 8-K
dated May 6, 2005. |
| | (ii) | Sample form of
Non-Statutory Stock Option Agreement under the Ecolab Inc. 2005 Stock
Incentive Plan – Incorporated by reference to Exhibit (10)B of our Form 8-K
dated May 6, 2005. |
| | (iii) | Sample form of
Restricted Stock Award Agreement under the Ecolab Inc. 2005 Stock Incentive
Plan – Incorporated by reference to Exhibit (10)W(iii) of our Form 10-K
Annual Report for the year ended December 31, 2006. |
| (13) | Those portions of our
Annual Report to Stockholders for the year ended December 31, 2007 which
are incorporated by reference into Parts I and II hereof. | |
| (21) | List of Subsidiaries as
of February 15, 2008. | |
| (23) | Consent of Independent
Registered Public Accounting Firm at page 32 hereof is filed as a part hereof. | |
| (24) | Powers of Attorney. | |
| (31) | Rule 13a-14(a) Certifications. | |
| (32) | Section 1350
Certifications. | |

29

SEQ.=1,FOLIO='29',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-07.htm',USER='cjensena',CD='Feb 25 11:09 2008'

*EXECUTIVE COMPENSATION PLANS AND ARRANGEMENTS*

Included in the preceding list of exhibits are the following management contracts or compensatory plans or arrangements:

Exhibit No. Description
(10)C. Ecolab Inc. 1997
Stock Incentive Plan.
(10)D. 1995
Non-Employee Director Stock Option Plan.
(10)E. Ecolab Inc. 2001
Non-Employee Director Stock Option and Deferred Compensation Plan.
(10)G. Form of
Director Indemnification Agreement.
(10)H. Ecolab Executive
Death Benefits Plan.
(10)I. Ecolab Executive
Long-Term Disability Plan.
(10)J. Ecolab Executive
Financial Counseling Plan.
(10)K. Ecolab
Supplemental Executive Retirement Plan.
(10)L. Ecolab Mirror
Savings Plan.
(10)M. Ecolab Mirror
Pension Plan.
(10)N. Ecolab Inc.
Administrative Document for Non-Qualified Benefit Plans.
(10)O. Ecolab Inc.
Management Performance Incentive Plan.
(10)P. Ecolab Inc.
Change in Control Severance Compensation Policy.
(10)R. Ecolab Inc. 2002
Stock Incentive Plan.
(10)S. 2008 Named
Executive Officer Summary of Base Salary, Bonus Award Opportunities, and
Executive Benefits and Perquisites.
(10)T. Non-Employee
Director Compensation and Benefits Summary.
(10)U. Ecolab Inc. 2005
Stock Incentive Plan.

30

SEQ.=1,FOLIO='30',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-07.htm',USER='cjensena',CD='Feb 25 11:09 2008'

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, Ecolab Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 25 th day of February, 2008.

ECOLAB INC.
(Registrant)
By: /s/Douglas M. Baker, Jr.
Douglas M. Baker, Jr.
Chairman of the Board, President
and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of Ecolab Inc. and in the capacities indicated, on the 25 th day of February 2008.

| /s/Douglas
M. Baker, Jr. | Chairman
of the Board, President |
| --- | --- |
| Douglas
M. Baker, Jr. | and
Chief Executive Officer (Principal Executive Officer and Director) |
| /s/Steven L. Fritze | Chief
Financial Officer |
| Steven L. Fritze | (Principal Financial Officer) |
| /s/Daniel J. Schmechel | Senior Vice President and Controller |
| Daniel J. Schmechel | (Principal Accounting Officer) |
| /s/Lawrence
T. Bell | Directors |
| Lawrence
T. Bell | |
| as attorney-in-fact
for: Les S. Biller, Richard U. De Schutter, Stefan Hamelmann, Jerry A.
Grundhofer, Joel W. Johnson, Jerry W. Levin, Robert L. Lumpkins, Beth M.
Pritchard, Kasper Rorsted, Hans Van Bylen and John J. Zillmer | |
| Director
not signing: Barbara J. Beck | |

31

SEQ.=1,FOLIO='31',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-07.htm',USER='cjensena',CD='Feb 25 11:09 2008'

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Registration Nos. 2-60010; 2-74944; 33-1664; 33-41828; 2-90702; 33-18202; 33-55986; 33-56101; 333-95043; 333-109890; 33-26241; 33-34000; 33-56151; 333-18627; 333-109891; 33-39228; 33-56125; 333-70835; 33-60266; 333-95041; 33-65364; 333-18617; 333-79449; 333-40239; 333-95037; 333-50969; 333-58360; 333-97927; 333-115567; 333-129427; 333-129428; 333-140988; 333-115568; 333-132139; and 333-147148) and Form S-3 (Registration No. 333-147052) of Ecolab Inc. of our report dated February 22, 2008 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in the Annual Report to Shareholders, which is incorporated in this Annual Report on Form 10-K.

PricewaterhouseCoopers
LLP
Minneapolis,
Minnesota
February 25,
2008

32

SEQ.=1,FOLIO='32',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-07.htm',USER='cjensena',CD='Feb 25 11:09 2008'

EXHIBIT INDEX

The following documents are filed as exhibits to this Report.

Exhibit No. Document Method of Filing
(3) A. Restated
Certificate of Incorporation of Ecolab Inc., dated as of February 27,
2006, effective as of March 13, 2006. Incorporated by
reference to Exhibit (3)A of our Form 10-K Annual Report for the
year ended December 31, 2005.
B. Certificate of
Designation, Preferences and Rights of Series A Junior Participating
Preferred Stock of Ecolab Inc., dated as of February 27, 2006, effective
as of March 13, 2006. Incorporated by
reference to Exhibit (3)C of our Form 10-K Annual Report for the
year ended December 31, 2005.
C. By-Laws, as
amended through February 22, 2008. Filed herewith
electronically.
(4) A. Common Stock. See Exhibits
(3)A and (3)C.
B. Form of
Common Stock Certificate effective February 28, 2007. Incorporated by
reference to Exhibit (4)B of our Form 10-K Annual Report for the
year ended December 31, 2006.
C. Rights
Agreement, dated as of February 24, 2006, between Ecolab Inc. and
Computershare Investor Services, LLC, as Rights Agent, which includes the
following exhibits thereto: (i) Exhibit A — Form of
Certificate of Designation, Preferences and Rights of Series A Junior
Participating Preferred Stock and (ii) Exhibit B — Form of
Rights Certificate. Incorporated by
reference to Exhibit (4)C of our Form 10-K Annual Report for the
year ended December 31, 2005.
D. Second Amended
and Restated Stockholder’s Agreement between Henkel KGaA and Ecolab Inc.,
dated November 30, 2001. Incorporated by reference
to Exhibit (4) of our Form 8-K dated November 30, 2001.
E. Amended and
Restated Indenture dated as of January 9, 2001 between Ecolab Inc. and
The Bank of New York Trust Company, N.A. Incorporated by
reference to Exhibit (4)(A) of our Current Report on Form 8-K
dated January 23, 2001.
F. Officer’s
Certificate establishing terms and conditions of 6.875% Notes due
February 1, 2011. Incorporated by
reference to Exhibit 4(B) of our Form 8-K dated
January 23, 2001.
G. Form of
6.875% Note due February 2, 2011. Incorporated by
reference to Exhibit 4(c) of our Form 8-K dated
January 23, 2001.

Exhibits - 1

SEQ.=1,FOLIO='Exhibits - 1',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-07.htm',USER='cjensena',CD='Feb 25 11:09 2008'

| Exhibit No. | H. | | Document — Supplemental Indenture,
dated as of February 8, 2008, between Ecolab Inc. and The Bank of New
York Trust Company, N.A., as Trustee. | Method of Filing — Incorporated by
reference to Exhibit 4.2 of our Current Report on Form 8-K dated
February 8, 2008. |
| --- | --- | --- | --- | --- |
| | I. | | Form 4.875%
Note due February 15, 2015. | Included in
Exhibit (4)H above. |
| (10) | A. | (i) | Multicurrency Credit
Agreement, dated as of September 29, 1993, as amended and restated as of
June 1, 2006, among Ecolab Inc., the financial institutions party
thereto as Banks from time to time, the financial institutions party thereto
as Issuing Banks from time to time, Citibank, N.A., as administrative agent
for the Banks and Issuing Banks thereunder, Citibank International PLC, as
agent for the Banks in connection with certain of the Eurocurrency Advances,
and JPMorgan Chase Bank, N.A., as syndication agent. | Incorporated by
reference to Exhibit (10) of our Form 8-K dated June 1,
2006. |
| | | (ii) | Extension
Confirmation Notice, dated May 14, 2007, under the Multicurrency Credit
Agreement, dated as of September 29, 1993, as amended and restated as of
June 1, 2006. | Incorporated by
reference to Exhibit (10) of our Form 8-K dated May 14,
2007. |
| | | (iii) | Increase of
Commitments Agreement dated as of October 29, 2007 by and among Ecolab
Inc., Citibank, N.A., JPMorgan Chase Bank, N.A., Credit Suisse, Cayman
Islands Branch, National Association, Wells Fargo Bank, National Association,
ABN AMRO Bank N.A., Bank of America, N.A. and Barclays Bank PLC, as
increasing banks, and Citibank, N.A., as agent. | Incorporated by
reference to Exhibit (10) of our Form 10-Q for the quarter
ended September 30, 2007. |
| | B. | | Documents
comprising global Commercial Paper Programs. | |
| | | (i) | U.S. $200,000,000 Euro-Commercial Paper Programme. | |
| | | | (a) Amended and Restated Dealer Agreement dated 2
December 2005 between Ecolab Inc. (as Guarantor), Ecolab B.V. and Ecolab
Holding GmbH (as Issuers), Ecolab Inc., Credit Suisse First Boston (Europe)
Limited (as Arranger), and Citibank International plc and Credit Suisse First
Boston (Europe) Limited (as Dealers). | Incorporated by
reference to Exhibit (10)B(i)(a) of our Form 10-K Annual
Report for the year ended December 31, 2005. |
| | | | (b) Amended and Restated Note Agency Agreement dated
as of 2 December 2005 between Ecolab Inc., Ecolab B.V. and Ecolab
Holding GmbH (as Issuers) and Citibank, N.A. as Issue and Paying Agent. | Incorporated by
reference to Exhibit (10)B(i)(b) of our Form 10-K Annual
Report for the year ended December 31, 2005. |

Exhibits - 2

SEQ.=1,FOLIO='Exhibits - 2',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-07.htm',USER='cjensena',CD='Feb 25 11:09 2008'

Exhibit No. Document Method of Filing
(c) Deed of Covenant made on 2 December 2005 by
Ecolab Inc., Ecolab B.V. and Ecolab Holding GmbH. Incorporated by
reference to Exhibit (10)B(i)(c) of our Form 10-K Annual
Report for the year ended December 31, 2005.
(d) Deed of Guarantee made on 2 December 2005. Incorporated by
reference to Exhibit (10)B(i)(d) of our Form 10-K Annual
Report for the year ended December 31, 2005.
(ii) U.S.
$600,000,000 U.S. Commercial Paper Program.
(a) Form of Commercial Paper Dealer Agreement for
4 (2) Program. Agreements have been executed with Salomon Smith
Barney, Inc. and Banc One Capital Markets, Inc. Incorporated by
reference to Exhibit (10)A(ii)(a) of our Form 10-Q for the
quarter ended June 30, 2003.
(b) Issuing and Paying Agency Agreement dated as of
July 10, 2000 between Ecolab Inc. and Bank One, National Association as
Issuing and Paying Agent. Incorporated by reference
to Exhibit (10)A(ii)(b) of our Form 10-Q for the quarter ended
June 30, 2003.
C. (i) Ecolab Inc. 1997
Stock Incentive Plan, as Amended and Restated as of August 18, 2000. Incorporated by
reference to Exhibit (10) of our Form 10-Q for the quarter
ended September 30, 2000.
(ii) Non-Statutory
Stock Option Agreement as in effect for grants through May 12, 2000. Incorporated by
reference to Exhibit (10)B(i) of our Form 10-Q for the quarter
ended June 30, 2004.
(iii) Non-Statutory
Stock Option Agreement as in effect for grants beginning May 13, 2000
through May 10, 2002. Incorporated by
reference to Exhibit (10)B(ii) of our Form 10-Q for the
quarter ended June 30, 2004.
D. (i) 1995
Non-Employee Director Stock Option Plan. Incorporated by
reference to Exhibit (10)D(i) of our Form 10-K Annual Report
for the year ended December 31, 2006.
(ii) Amendment
No. 1 to 1995 Non-Employee Director Stock Option Plan effective
February 25, 2000. Incorporated by
reference to Exhibit (10)E(ii) of our Form 10-K Annual Report
for the year ended December 31, 1999.
(iii) Amendment
No. 2 to 1995 Non-Employee Director Stock Option Plan effective
May 11, 2001. Incorporated by
reference to Exhibit (10)G(iii) of our Form 10-K Annual Report
for the year ended December 31, 2002.

Exhibits - 3

SEQ.=1,FOLIO='Exhibits - 3',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-07.htm',USER='cjensena',CD='Feb 25 11:09 2008'

Exhibit No. Document Method of Filing
E. (i) Ecolab Inc. 2001
Non-Employee Director Stock Option and Deferred Compensation Plan as amended
effective May 1, 2004. Incorporated by
reference to Exhibit (10)H(ii) of our Form 10-K Annual Report
for the year ended December 31, 2003.
(ii) Amendment No. 1
adopted December 15, 2004 to Ecolab Inc. 2001 Non-Employee Director Stock
Option and Deferred Compensation Plan, as amended and restated effective May
1, 2004, with respect to the American Jobs Creation Act of 2004. Incorporated by
reference to Exhibit (10)F(ii) of our Form 10-K Annual Report
for the year ended December 31, 2004.
(iii) Master Agreement
Relating to Options (as in effect through May 7, 2004). Incorporated by
reference to Exhibit (10)D(i) of our Form 10-Q for the quarter
ended June 30, 2004.
(iv) Master Agreement
Relating to Periodic Options, as amended effective as of May 1, 2004. Incorporated by
reference to Exhibit (10)D(ii) of our Form 10-Q for the
quarter ended June 30, 2004.
F. Note Purchase
Agreement, dated as of July 26, 2006 by and among Ecolab Inc. and the
Purchasers party thereto. Incorporated by
reference to Exhibit (10) of our Form 8-K dated July 26,
2006.
G. Form of
Director Indemnification Agreement. Substantially identical agreements are in
effect as to each of our directors. Incorporated by
reference to Exhibit (10)I of our Form 10-K Annual Report for the
year ended December 31, 2003.
H. (i) Ecolab Executive Death
Benefits Plan, as amended and restated effective March 1, 1994. See also
Exhibit (10)N hereof. Incorporated
by reference to Exhibit (10)H(i) of our Form 10-K Annual
Report for the year ended December 31, 2006. See also Exhibit (10)N
hereof.
(ii) Amendment
No. 1 to Ecolab Executive Death Benefits Plan. Incorporated by
reference to Exhibit (10)H(ii) of our Form 10-K Annual Report
for the year ended December 31, 1998.
(iii) Second Declaration of
Amendment to Ecolab Executive Death Benefits Plan, effective March 1,
1998. Incorporated by
reference to Exhibit (10)H(iii) of our Form 10-K Annual Report
for the year ended December 31, 1998.
(iv) Amendment No. 3 to
the Ecolab Executive Death Benefits Plan, effective August 12, 2005. Incorporated by
reference to Exhibit (10)B of our Form 8-K dated December 13,
2005.

Exhibits - 4

SEQ.=1,FOLIO='Exhibits - 4',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-07.htm',USER='cjensena',CD='Feb 25 11:09 2008'

Exhibit No. Document Method of Filing
I. Ecolab Executive
Long-Term Disability Plan, as amended and restated effective January 1,
1994. See also Exhibit (10)N hereof. Incorporated by
reference to Exhibit (10)I of our Form 10-K Annual Report for the
year ended December 31, 2004.
J. Ecolab Executive
Financial Counseling Plan. Incorporated by
reference to Exhibit (10)J of our Form 10-K Annual Report for the
year ended December 31, 2004.
K. (i) Ecolab Supplemental
Executive Retirement Plan, as amended and restated effective January 1,
2003. Incorporated by
reference to Exhibit (10)M of our Form 10-K Annual Report for the
year ended December 31, 2003.
(ii) Amendment No. 1
and Instrument of Benefit Freeze adopted December 16, 2004 to the Ecolab
Supplemental Executive Retirement Plan (As Amended and Restated effective
January 1, 2003) With Respect to the American Jobs Creation Act of 2004. Incorporated by
reference to Exhibit (10)K(ii) of our Form 10-K Annual Report
for the year ended December 31, 2004.
L. (i) Ecolab Mirror Savings
Plan, as amended and restated effective as of March 1, 2002. Incorporated
by reference to Exhibit (10)N of our Form 10-K Annual Report for
the year ended December 31, 2002.
(ii) Amendment No. 1
adopted December 16, 2004 to the Ecolab Mirror Savings Plan (As Amended
and Restated Effective as of March 1, 2002) With Respect to the American
Jobs Creation Act of 2004. Incorporated by
reference to Exhibit (10)L(ii) of our Form 10-K Annual Report
for the year ended December 31, 2004.
(iii) Amendment No. 2 to
the Ecolab Mirror Savings Plan, effective January 1, 2005. Incorporated by
reference to Exhibit (10)A of our Form 8-K dated December 13,
2005.
M. (i) Ecolab Mirror
Pension Plan, as amended and restated effective as of January 1, 2003. Incorporated by
reference to Exhibit (10)B of our Form 10-Q for the quarter ended
June 30, 2003. See also Exhibit (10)N hereof.
(ii) Amendment No. 1 and
Instrument of Benefit Freeze adopted December 16, 2004 to the Ecolab
Mirror Pension Plan (As Amended and Restated effective January 1, 2003)
With Respect to the American Jobs Creation Act of 2004. Incorporated by
reference to Exhibit (10)M(ii) of our Form 10-K Annual Report
for the year ended December 31, 2004.
N. (i) Ecolab Inc.
Administrative Document for Non-Qualified Benefit Plans, as amended and
restated effective as of January 1, 2003. Incorporated by
reference to Exhibit (10)P of our Form 10-K Annual Report for the
year ended December 31, 2003.

Exhibits - 5

SEQ.=1,FOLIO='Exhibits - 5',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-07.htm',USER='cjensena',CD='Feb 25 11:09 2008'

Exhibit No. Document Method of Filing
(ii) Amendment No. 1
adopted December 16, 2004 to the Ecolab Inc. Administrative Document for
Non-Qualified Benefit Plans (As Amended and Restated effective
January 1, 2003) With Respect to the American Jobs Creation Act of 2004. Incorporated by
reference to Exhibit (10)N(ii) of our Form 10-K Annual Report
for the year ended December 31, 2004.
O. (i) Ecolab Inc. Management
Performance Incentive Plan, as amended and restated on February 28,
2004. Incorporated by
reference to Exhibit (10)A of our Form 10-Q for the quarter ended
March 31, 2004.
(ii) Amendment No. 1
adopted February 26, 2005 to the Ecolab Inc. Management Performance
Incentive Plan. Incorporated by
reference to Exhibit (10)O(ii) of our Form 10-K Annual Report
for the year ended December 31, 2004.
P. Ecolab Inc. Change in
Control Severance Compensation Policy, effective February 22, 2002. Incorporated
by reference to Exhibit (10)R of our Form 10-K Annual Report for
the year ended December 31, 2001.
Q. (i) Master Agreement, dated
as of December 7, 2000, between Ecolab Inc. and Henkel KGaA. Incorporated by
reference to Exhibit 18 of HC Investments, Inc.’s and Henkel KGaA’s
Amendment No. 5 to Schedule 13D dated December 14, 2000.
(ii) Amendment No. 1 to
the Master Agreement, dated December 7, 2000, between Ecolab Inc. and
Henkel KGaA. Incorporated
by reference to Exhibit (10) of our Form 10-Q for the quarter
ended September 30, 2001.
(iii) Intellectual Property
Agreement dated November 30, 2001, between Ecolab and Henkel KGaA. Incorporated
by reference to Exhibit (10) of our Form 8-K dated
November 30, 2001.
R. (i) Ecolab Inc. 2002 Stock
Incentive Plan. Incorporated
by reference to Exhibit (10) of our Form 10-Q for the quarter
ended June 30, 2002.
(ii) Non-statutory Stock
Option Agreement as in effect for grants beginning May 11, 2002 through
August 12, 2003. Incorporated
by reference to Exhibit (10)A(i) of our Form 10-Q for the
quarter ended June 30, 2004.
(iii) Non-statutory Stock
Option Agreement as in effect for grants beginning August 13, 2003. Incorporated
by reference to Exhibit (10)A(ii) of our Form 10-Q for the
quarter ended June 30, 2004.

Exhibits - 6

SEQ.=1,FOLIO='Exhibits - 6',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-07.htm',USER='cjensena',CD='Feb 25 11:09 2008'

Exhibit No. Document Method of Filing
S. 2008 Named Executive
Officer Summary of Base Salary, Bonus Award Opportunities, and Executive
Benefits and Perquisites. Filed
herewith electronically.
T. Non-Employee Director
Compensation and Benefits Summary. Filed herewith
electronically.
U. (i) Ecolab Inc. 2005 Stock
Incentive Plan. Incorporated by
reference to Exhibit (10)A of our Form 8-K dated May 6, 2005.
(ii) Sample form of
Non-Statutory Stock Option Agreement under the Ecolab Inc. 2005 Stock
Incentive Plan. Incorporated by
reference to Exhibit (10)B of our Form 8-K dated May 6, 2005.
(iii) Sample form of
Restricted Stock Award Agreement under the Ecolab Inc. 2005 Stock Incentive
Plan Incorporated by
reference to Exhibit (10)W(iii) of our Form 10-K Annual Report
for the year ended December 31, 2006.
(13) Those portions of our
Annual Report to Stockholders for the year ended December 31, 2007 which
are incorporated by reference into Parts I and II hereof. Filed
herewith electronically
(21) List of Subsidiaries as
of February 15, 2008. Filed
herewith electronically
(23) Consent of Independent
Registered Public Accounting Firm at page 32 hereof is filed as a part
hereof. See
page 32 hereof.
(24) Powers of Attorney. Filed
herewith electronically.
(31) Rule 13a-14(a) Certifications. Filed
herewith electronically.
(32) Section 1350
Certifications. Filed herewith
electronically

Exhibits - 7

SEQ.=1,FOLIO='Exhibits - 7',FILE='C:\JMS\cjensena\08-6080-1\task2722715\6080-1-ba-07.htm',USER='cjensena',CD='Feb 25 11:09 2008'